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Abstract 
The endoplasmic reticulum (ER)-associated NADH cytochrome b5 oxidoreductase (Ncb5or) 
is widely distributed in animal tissues. It contains two redox domains that are homologous to 
microsomal cytochrome b5 (Cyb5A) at the N terminus and its cognate reductase (Cyb5R3) at the C 
terminus. Ncb5or null mice develop diabetes at age 7 weeks and have increased susceptibility to the 
diabetogenic agent streptozotocin. Ncb5or deficiency also results in lipoatrophy and increased 
hepatocyte sensitivity to cytotoxic effects of saturated fatty acids. Here we investigate the 
mechanisms of these phenomena in prediabetic Ncb5or
-/- 
mice.  We find that, despite increased rates 
of fatty acid uptake and synthesis and higher stearoyl-CoA desaturase (SCD) expression, Ncb5or
 -/-
 
liver accumulates less triacylglycerol (TAG) than wild-type (WT). Ncb5or
-/-
 hepatocytes readily 
incorporate exogenous fatty acids into TAG but accumulate more free fatty acids (FFA). A high-fat 
diet rich in palmitate and oleate stimulates both lipogenesis and fatty acid catabolism in Ncb5or
 -/-
 
liver, resulting in TAG levels similar to WT but increased intracellular FFA accumulation.  Hepatic 
SCD specific activity is 2-fold lower in Ncb5or
-/-
 than in WT mice when up to 8 fold increases in 
Scd1 mRNA and protein levels are considered. Accumulation of saturated fatty acids in Ncb5or
-/-
 
hepatocytes increases mitochondrial content, peroxisome proliferator-activated receptor-γ 
coactivator 1α (PGC-1α) expression, fatty acid oxidation rates, oxidative stress response gene 
expression, oxidized glutathione content and cell death. These phenotypes could be alleviated by 
co-incubation with oleic acid via TAG channeling. Taken together, these findings suggest that 
increased FFA accumulation and catabolism and oxidative stress are major consequences of Ncb5or
 
deficiency in liver. Our study has provided new insight into fatty acid metabolism and revealed a 
novel role of Ncb5or in preventing saturated fatty acid induced oxidative stress.  
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1.1 Ncb5or and its biology 
1.1.1 Ncb5or  
NADH cytochrome b5 oxidoreductase (Ncb5or) is a highly conserved enzyme in 
the animal kingdom and is widely expressed in most tissues [1].  It was identified  from 
bioinformatics search of novel proteins that contain  NAD(P)H and flavin binding sites in 
the expressed sequence tag (EST) database [1]. After the cDNA was cloned from human 
cell lines, Ncb5or was found to contain two redox domains that are homologous to 
microsomal cytochrome b5 (b5, encoded by Cyb5A) at the N terminus and cytochrome 
b5 reductase (b5R, encoded by Cyb5R3) at the C terminus. These two domains are 
connected by a hinge domain, which contains a well conserved CHORD and SGT1 (CS) 
motif [2]. Similar to other b5 and b5R proteins, the b5 domain of Ncb5or contains heme, 
and the b5R domain has flavin-adenine dinucleotide (FAD) and NAD(P)H binding 
domains [3; 4]. Unlike their single-domain homologs, however, Ncb5or has no known 
membrane anchor. A recent study from our laboratory provides the x-ray crystal structure 
of the b5 domain of Ncb5or, revealing a unique heme environment compared to that in 
other members of the b5 superfamily [5].   
Ncb5or in animals is a unique protein family because it is the first example of a 
natural fusion protein of b5, CS and b5R domains found in animals. It is a soluble protein 
associated with ER [6] and able to reduce cytochrome c, methemoglobin, ferricyanide 
and molecular oxygen in vitro.  Its low redox potential, -0.108 V at the heme center [6]  
makes it a more potent electron donor than Cyb5A, whose redox potential is around 0 V 
[7; 8].  
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There is one functional Ncb5or gene in each animal, although a pseudogene has 
been found in mouse and rat genomes. All Ncb5or genes have 16 exons with conserved 
splicing sites.  Interestingly, rat and mouse also generate a splice variant of Ncb5or, 
which is highly expressed in testis, brain and skeletal muscle [9]. This splice variant is 
considered to be a dominant negative form because it lacks the entire exon 12, which 
encodes the FAD binding site [9]. Promoter batching studies showed that the 5’ UTR 
regions at 216-157 bp and 60-30 bp upstream of the transcription start site are the two 
most important regions for the promoter activity [10]. In addition, a consensus ARE 
(antioxidant-response element) was found in the Ncb5or promoter region, suggesting a 
potential role of Ncb5or in antioxidant response [11]. 
1.1.2 Cytochrome b5 and its cognate reductase 
Cytochrome b5 is a ubiquitous heme protein involved in numerous cellular 
processes. It has two isoforms in mammals, microsomal cytochrome b5 (Cyb5A) and 
outer mitochondrial cytochrome b5 (Cyb5B) [12]. Cyb5A can form a complex with its 
cognate reductase, Cyb5R3, in the ER membranes, which has been shown to function as 
an electron donor of ∆
9
 stearoyl-CoA desaturase (SCD) in vitro to reconstitute fatty acid 
desaturation [13-15]. Genetic studies of human patients with methemoglobinemia show 
that soluble forms of Cyb5A and Cyb5R3 proteins are responsible to reduce 
methemoglobin to hemoglobin [16; 17].   
Cyb5A can also modulate cytochrome P450 activity, which is involved in a 
number of processes including cholesterol, steroid hormone, exogenous xenobiotics and 
drug metabolism in vitro [18- 22] and in vivo [23]. In the latter case, hepatic b5 null 
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(HBN) mice , in which Cyb5A is disrupted specifically in hepatocytes, showed a major 
P450-dependent defect in drug and chemical metabolism [23]. However, no fatty acid 
desaturation defect was observed due to the similarity between these mice and wild-type 
(WT) littermates in hepatic lipid profiles [23] and SCD activity (H. Zhu, unpublished 
data). Subsequently, a global Cyb5A null mouse model (BCN) was also generated, and 
their liver phenotype further supported the role of Cyb5A in drug metabolism in vivo [24]. 
BCN mice also showed 10-fold higher levels of methemoglobin in red blood cells and a 
minor SCD defect in total hepatic lipids compared to WT [25]. Cyb5B is located in outer-
mitochondrial membrane. It was found to play a role in androgen synthesis in Leydig 
cells [26]. However, its biological function is still not fully understood.  
Cytochrome b5 reductase (Cyb5R3) is a member of ferredoxin: NADP
+
 reductase 
superfamily and contains well conserved FAD and NAD(P)H binding sites [4].  Cyb5R3 
has been found to localize in  ER and mitochondria to reduce both Cyb5A and Cyb5B 
[27]. More than thirty missense mutations in Cyb5R3 gene have been identified in 
methemoglobinemia patients [28], but none in other diseases.  
1.1.3 Ncb5or
-/-
 mouse model 
The biological function of Ncb5or was revealed in 2004 by the phenotypes of 
Ncb5or
-/-
 mouse. A majority of these mice started to develop diabetes around 7 weeks of 
age [29], and they were more sensitive to diabetogenic agent streptozotocin (STZ) [30]. 
Notably, the insulin sensitivity in these Ncb5or
-/-
 mice was not altered [29]. Due to the 
normal insulin sensitivity and lack of lymphocyte infiltration, the diabetes mellitus in 
Ncb5or
-/-
 mice does not belong to either type 2 or autoimmune mediated type 1diabetes. 
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Instead, it is similar to maturity onset diabetes in the young (MODY) in the sense that 
these subtypes of diabetes are caused by mutations in a single gene to alter the beta-cell 
function [31; 32]. Screening of human patients with non-inflammatory diabetes, such as 
MODY and Type 2 diabetes, failed to identify mutations in Ncb5or gene [33].  
Our most recent work shows that beta cell dysfunction and loss in Ncb5or
-/-
 mice 
is associated with fatty acid overload, oxidative and ER stress [34].  The onset of diabetes 
is delayed by two weeks in mice that lack both Ncb5or and Chop, a key gene involved in 
ER stress-induced cell death [35], or accelerated by two weeks on an alloxan-sensitive 
(ALS) genetic background [34].  A high-fat (HF) diet accelerates the onset of diabetes by 
2-3 weeks in Ncb5or
-/-
 mice through exacerbating ER stress in beta cells of these mice 
(W.F.Wang, unpublished data).  
The other major phenotype of Ncb5or
-/-
 (knockout, KO) mice is lipoatrophy. 
These mice had significantly lower body weight and smaller white adipose tissues (WAT) 
than WT [36]. Since diabetes is known to increase fatty acid catabolism due to deficiency 
in glucose metabolism, lipoatrophy could be caused by diabetes directly or by a diabetes-
independent source. To dissect these two possibilities, Ncb5or
-/-
 mice were transplanted 
with WT islets to prevent the development of diabetes. These transplanted KO (TKO) 
mice had similar fasting blood glucose levels and glucose tolerance as WT, but still 
developed lipoatrophy.  This evidence strongly suggests that lipoatrophy is independent 
of diabetes [36].  
Besides the loss of WAT, TKO mice also had lower lipid content and impaired ∆
9
 
fatty acid desaturation in liver than WT [36], indicating the role of Ncb5or in ∆
9 
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desaturation in vivo. Our recent studies show that Ncb5or
-/-
 hepatocytes are more 
susceptible than WT to SFA, not MUFA, with increased ER and cell death [35; 36]. 
Moreover, cytotoxicity of saturated fatty acid (SFA) and ER stress are attenuated by co-
treatment with monounsaturated fatty acid (MUFA) [35; 36]. Both in vivo and in vitro 
evidence leads us to hypothesize that Ncb5or plays an important role in fatty acid 
desaturation (Figure 1.1).  
1.1.4 Fatty acid ∆
9
desaturation 
  ∆
9
 fatty acid desaturation is important for triacylglycerol (TAG) synthesis [37], 
skin permeability and early liver and skin development [38]. This SCD pathway converts 
palmitic acid (C16:0) and stearic acid (C18:0) to palmitoleic acid (C16:1) and oleic acid 
(C18:1), respectively (Figure 1.1). So far, four SCD isoforms (SCD1-SCD4) have been 
identified in rodents [39]. SCD1 colocalizes with diacylglycerol acyltransferase 2 
(DGAT2, discussed below), which is a rate-limiting enzyme in TAG synthesis [40].  
Global SCD1 null mice are lean and protected from high-fat induced obesity [41]. 
Surprisingly, hepatic SCD1 null mice are protected from high-carbohydrate diet rather 
than high-fat diet induced obesity [42], indicating that hepatic SCD1 is mainly 
responsible for carbohydrate induced lipid synthesis. Although hepatic SCD1 is more 
involved in carbohydrate induced de novo lipogenesis, primary hepatocytes treated with 
SCD1 inhibitor were found to have increased apoptosis and cell death in response to 
palmitate [43], which suggests that SCD1 is also important for exogenous SFA 
metabolism for hepatocytes per se. In comparison, SCD2 has been shown to be crucial 
7 
 
for ∆
9
desaturation in early development [38]. Since SCD2 null mice die shortly after birth 
due to skin permeability, the role of SCD2 in the adult stage still remains unknown.  
SCDs have no intrinsic Cyb5A-like domain.  This is different from ∆
5
, ∆
6 
desaturases (FADS), which function in inflammatory and immune response [44] and have 
a Cyb5A-like domain fused to a desaturase domain [45; 46]. This suggests that SCD 
relies on separate electron donors. Cyb5A and Cyb5R3 have long been considered as 
electron donors of SCD [15] with electrons flowing from NADH to FAD (in Cyb5R3) to 
heme (in Cyb5A) and then to the iron center in SCDs for desaturation of fatty acids 
(Figure 1.1). However, BCN and HBN mice display mild or no defect in fatty acid 
desaturation [23; 25] suggesting that Cyb5A, along with its cognate reductase, is not an 
exclusive electron donor for SCDs. Prediabetic Ncb5or KO mice display a more severe 
defect in fatty acid desaturation than the Cyb5A KO mice, we thus hypothesize that 
Ncb5or functions as an alternative electron donor for SCDs in vivo.  
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Figure 1.1 Overview of ∆
9
 fatty acid desaturation.  Ncb5or contains two redox 
domains that are homologous to microsomal Cyb5A (b5) and Cyb5R3 (b5R). We 
hypothesize that Cyb5A/Cyb5R3 and Ncb5or can serve as electron donors for stearoyl-
CoA desaturase (SCD). SFA can be converted to MUFA by SCD, and electrons flow 
from NADH to FAD in b5R, to heme in b5 and then to iron in SCDs.   
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1.2 Fatty acid metabolism 
 Obesity affects more than 20% of the population in the Unites States [47] and has 
become a major health issue in the past 20 years. Obesity increases the risk of coronary 
heart disease, type 2 diabetes, cancers, hypertension, stroke, and fatty liver [48].  One 
major cause for these diseases is the significant increase in caloric intake and saturated fat 
content of an average Western diet, especially fast food. Based on these facts, a better 
understanding of fatty acid metabolism becomes increasingly important and can provide 
insight for potential intervention.  
1.2.1 Fatty acid metabolism pathways 
Fatty acids are categorized into three groups based on the number of double bonds 
in the hydrocarbon chain: saturated fatty acid (SFA), monounsaturated fatty acid (MUFA) 
and polyunsaturated fatty acid (PUFA) [49]. They can also be grouped on the basis of 
chain length to short-chain (fewer than 8 carbons), medium-chain (8-12 carbons), long-
chain (14-22 carbons), and very-long-chain (24 carbons or longer) fatty acids. SFA and 
MUFA come from both diets and de novo synthesis, whereas PUFAs only from diets.  
Dietary lipids contain mainly TAG with some free fatty acids (FFA) and 
cholesterol. These lipids are hydrolyzed by pancreatic lipases to monoacylglycerols and 
long-chain free fatty acids in the intestinal lumen. These fatty acids then enter enterocytes 
in the intestine and are resynthesized into diacylglycerol (DAG), TAG and cholesterol 
esters. They are packaged with apolipoprotein B to form lipoprotein particles, mainly as 
chylomicrons and very low-density lipoprotein (VLDL) particles, to enter the circulation 
via the lymph system. At tissue sites, such as liver and WAT, they are hydrolyzed to 
10 
 
release fatty acids by lipoprotein lipases (LPL). Upon entering cells through fatty acid 
transporters (FATPs), fatty acids are either bound by fatty acid-binding proteins (FABPs) 
and remain as free fatty acids (FFA), or be activated to CoA esters by long-chain fatty 
acid-CoA ligases (ACSLs) for re-esterification or fatty acid oxidation (Figure 1.2).   
In lipogenic cells, such as hepatocytes and adipocytes, activated fatty acids can be 
re-esterified into phospholipids and TAG. Phospholipids (PL) are major constituents of 
membranes and signal transduction whereas TAG is a major lipid form for energy reserve, 
especially in adipose tissues. In the latter, some SFAs need to be converted into MUFAs 
by stearoyl-CoA desaturase (SCD) for further processing. During the TAG or PL 
synthesis (Figure 1.3), glycerol-3-phosphate is first acylated to form lysophosphatidic 
acid (LPA) by glycerol-3-phosphate acyltransferase (GPAT) [50]. Then phosphatidic acid 
(PA) is formed by acylation of LPA by acylglycerol-3-phosphate acyltransferase 
(AGPAT). PA is then converted by phosphatidic acid phosphohydrolase (LIPIN) into 
DAG [51], which can form TAG by diacylglycerol acyltransferase (DGAT) [52].  
The major form of fatty acid oxidation is β-oxidation, which mainly occurs in 
mitochondria of skeletal and cardiac muscle. Acyl-CoA in cytosol is conjugated to 
carnitine by carnitine palmitoyltransferase (CPT), and then shuttled into mitochondria for 
β-oxidation. Acetyl-CoA, a major product of β-oxidation, can enter the tricarboxylic acid 
(TCA) cycle to generate NADH and FADH2, which then enter the electron transport 
chain (ETC) and oxidative phosphorylation to generate ATP.  
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Figure 1.2 Schematic diagram of cellular metabolism of saturated fatty acids (SFA). 
After SFA enters the cell, it can either stay as free SFA or be activated to its CoA esters 
by long-chain fatty acid-CoA ligases (ACSLs). The SFA-CoA can be oxidized to acetyl-
CoA through β-oxidation for energy or be re-esterified into phospholipids and TAG. 
Moreover, acetyl-CoAs can be utilized as substrate for de novo fatty acids synthesis by 
fatty acid synthase (FAS) to generate SFA. Both dietary and de novo synthesized SFA 
can be further converted to MUFA through SCD before entering TAG or PL pool. 
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Figures 1.3  Overview of lipid synthesis. Glycerol-3-phosphate from either 
dihyodroxyacetone phosphate (DHAP) or glycerol is acylated to form lysophosphatidic 
acid (LPA) by glycerol-3-phosphate acyltransferase (GPAT). Then acylglycerol-3-
phosphate acyltransferase (AGPAT) acylates LPA to phosphatidic acid (PA), which can 
be either further converted to glycerophospholipid by adding head groups or to 
diacylglycerol (DAG) by phosphatidic acid phosphohydrolase (LIPIN). Finally, TAG can 
be synthesized by diacylglycerol acyltransferase (DGAT) through acylating DAG. LPA, 
PA, glycerophospholipid and DAG can serve as signaling molecules. TAG is mainly used 
for energy reserves. 
13 
 
Fatty acids can come from de novo synthesis in the cytosol. The building block is 
acetyl-CoAs, which is generated from carbohydrates, fatty acid and other nutrients.  
Acetyl-CoAs are first carboxylated to malonyl-CoA by acetyl-CoA carboxylase (ACC). 
Then malonyl-CoA and acetyl-CoA can synthesize palmitate (C16:0), one species of SFA, 
by fatty acid synthase (FAS). Notably, malonyl-CoA is also an inhibitor for CPT by 
allosteric effect to decrease the β-oxidation rate to prevent futile cycling between β-
oxidation and fatty acid synthesis.  Both dietary and de novo palmitate can be further 
converted to MUFA through ∆
9 
desaturation pathways by the SCD or elongated to SFAs 
of longer lengths for different metabolic fates.  
MUFAs are preferred substrates of TAG synthesis, although both SFAs and 
MUFAs can be used. This is suggested by the fact that TAGs contain more MUFAs than 
SFAs [41] and that TAG synthesis is highly dependent on the expression of SCD [37].  
Similarly, both SFAs and MUFAs can be used in β-oxidation to generate acetyl CoAs. 
SFAs have been shown to cause lipotoxicity [53], which can be alleviated by MUFA 
through channeling intracellular SFA into the TAG pool, a much less toxic fatty acid 
form [54]. These observations indicate that SFA and MUFA are metabolized differently 
by cells and that the regulation of these metabolic fates is critically important.  
1.2.2 Regulation of fatty acid metabolism 
Lipid homeostasis is well controlled in the body. Under a fed state, the liver helps 
to synthesis TAGs and package them into lipoprotein particles for delivery to adipose 
TAG pool, in parallel to similar action in adipose tissues. Under fasting or after exercise, 
TAG in the adipose tissues is hydrolyzed by lipases including hormone-sensitive lipase 
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(HSL) and adipose triglyceride lipase (ATGL). The products, free fatty acids and glycerol, 
then enter circulation to other tissues as sources of energy.  
Fatty acid oxidation is stimulated by fasting. One regulator of this process is 5’ 
AMP-activated protein kinase (AMPK), which plays a key role in cellular energy 
homeostasis. When the AMP:ATP ratio within the cell increases (indicating a need for 
ATP or energy), AMP will bind to AMPK γ subunit to change the conformation of 
AMPK. This results in exposing the active site (Thr-172) of the α subunit for 
phosphorylation by upstream kinase, Serine/threonine kinase 11 (LKB1) [55-57]. Upon 
activation, phosphorylated AMPK inactivates ACC [58], which in turn decreases levels 
of malonyl-CoA and its inhibition on CPT. As a result, more fatty acids are transported 
by CPT into the mitochondria, which increases the rate of β-oxidation.  
PGC1α is a transcriptional coactivator that is involved in mitochondrial 
biogenesis, utilization of energy substrates like fatty acids and cellular respiration 
induction. For example, nuclear respiratory factor 1 and 2 (NRF1 and NRF2, respectively) 
are two downstream targets of PGC1α [59], which are essential for mitochondrial DNA 
replication, maintenance and transcription [60; 61]. They also play important roles in 
regulating expression of genes that are involved in mitochondrial ETC and maintaining 
proper mitochondrial function [62; 63]. Recently, NRF1 is found to bind antioxidant 
response element (ARE) to induce antioxidant  enzymes [64].  
PGC1α exerts its function by interacting and coactivating a variety of genes 
including peroxisome proliferator-activated receptor α (PPARα), γ (PPARγ) and δ or β 
(PPARδ/β). PPARs are a group of nuclear receptors that function as transcription factors 
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to regulate the expression of downstream targets involved in lipid or carbohydrate 
metabolism, cellular differentiation and development [65]. Upon activation, they 
heterodimerize with retinoid X receptor (RXR) and then bind to specific peroxisome 
proliferator response elements (PPREs) in promoter region of target genes [66]. PPARα 
is mainly expressed in the liver, heart and skeletal muscle. It can be activated by a wide 
range of SFA and MUFAs [67] and induce pathways of β-oxidation [67; 68]. Recently, it 
was found to be a dominant regulator for dietary fatty acid induced hepatic gene 
expression [69]. PPARγ is primarily expressed in adipose tissue to regulate adipocyte 
differentiation and lipogenesis [70] and PUFAs are preferred natural ligands of PPARγ 
[71]. PPARδ/β is ubiquitously expressed in most tissues including livers, and similar to 
PPARα, is induced by fatty acids to regulate fatty acid oxidation [71]. Recent data 
suggest that PPARδ/β, rather than PPARα, is responsible for sensing plasma FFA in liver 
[72] and that fatty acid activation enzyme, ACSL3, is a downstream molecular target [73].  
Sirtuin (SIRT1) is another key regulator of PGC1α. SIRT1 is a nuclear NAD
+
-
dependent protein deacetylase. It senses NAD
+
/NADH ratio, and is activated by 
increased intracellular level of NAD
+ 
[74]. Upon activation, it deacetylates PGC1α [75]. 
AMPK is also involved in inducing SIRT1 activity by increasing cellular NAD
+
 levels 
through activating fatty acid oxidation [76]. Moreover, AMPK-dependent 
phosphorylation of PGC1α is required for deacetylation by SIRT1 [76], further 
supporting the role of AMPK in energy homeostasis. PGC1α can be induced by other 
stimuli including reactive oxygen species (ROS) [77] and p38 mitogen-activated protein 
kinases (p38 MAPK), a stress sensor [78]. In conclusion, AMPK, PPARs and PGC1α 
play essential roles in the maintenance of energy balance, especially lipid metabolism.  
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1.3 Lipotoxicity 
Fatty acid metabolism is well balanced and regulated under physiological states. 
However, when the intake of fatty acids is much greater than the usage, excess lipids 
accumulate in both adipose and non-adipose tissues, including liver, heart, pancreas and 
muscle, resulting in obesity. A balanced fatty acid metabolism is critical for energy 
homeostasis, membrane structure and intracellular signaling. Over-accumulation of free 
fatty acids will impair cell function and even cause cell death [79], a phenomenon called 
“lipotoxicity”.  
Among all fatty acids, free SFA is considered the most toxic one. SFA can induce 
C-jun N-terminal kinase (JNK) dependent apoptosis in the cells by activating 
proapoptotic proteins Bcl-2-associated X protein (Bax), leading to mitochondrial 
membrane permeabilization, cytochrome c release, and caspase 3 and 7 activation [80]. 
This evidence suggests that apoptosis is one of the major ways for SFA-induced cell 
death, although the mechanism is still not fully understood.  
There are several models of SFA-induced cytotoxicity. The first one is ceramide-
mediated pathway. Ceramide is a lipid second messenger known to induce apoptosis. 
Palmitate is the major substrate for ceramide synthesis and accumulation of palmitate is 
found to increase de novo ceramide synthesis, resulting in apoptosis [81].  
The second model is phospholipid remodeling. Under physiological conditions, 
phospholipids in the membrane have a well-balanced ratio of MUFA vs. SFA. However, 
accumulation of SFA has been found to lead to phospholipid remodeling, causing a 
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significantly decrease in the MUFA:SFA ratio [82]. As a consequence, membrane 
fluidity and function is disrupted, which leads to dysfunction of mitochondria [82].  
The third one is oxidative stress. SFA has been shown to induce oxidative stress, 
which can impair membrane integrity, oxidize DNA and proteins and destroy organelles 
in the cells [83; 84]. Several possible causes of oxidative stress by SFA are 1) electron 
leakage from mitochondrial ETC as a result of increased β-oxidation rate; 2) 
mitochondrial dysfunction caused by membrane phospholipid remodeling, cytochrome c 
release and disruption of mitochondrial respiratory chain complex III; 3) increased 
NAPDH oxidase (NOX), which can generate superoxide upon induction by increased 
diacylglycerol (DAG) level generated from excess SFA [85].  
The fourth model is ER stress. SFA can induce ER stress in various cell types [35; 
86; 87], potentially due to remodeling of ER membrane lipids or via oxidative stress. In 
short, over-accumulation of lipids, especially SFA, is toxic to many cell types and leads 
to diseases such as diabetes and fatty liver. 
 
1.4 Oxidative stress  
1.4.1 Reactive oxygen species 
Oxidative stress occurs when there is more generation of reactive oxygen species 
(ROS) than the removal by anti-oxidant defense. Superoxide (O2
-
), hydrogen peroxide 
(H2O2) and hydroxyl radicals (HO
.
) are three forms of ROS. O2
- 
forms when oxygen is 
attacked by electrons and becomes partially reduced. Superoxide dismutase (SOD), such 
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as CuZn-SOD (SOD1) in the cytosol and Mn-SOD (SOD2) in mitochondria, dismutates 
superoxide to H2O2. At high concentrations, H2O2 is converted into H2O by catalase, or at 
low concentrations, by glutathione peroxidase. When interacted by transition metals, such 
as Fe
2+
, H2O2 will form hydroxyl free radicals (HO
.
), which is the most potent ROS.  This 
process is called Fenton reaction [49]. 
ROS can be produced under diverse stimuli including pro-inflammatory cytokines 
[88], ultraviolet irradiation, nutrient metabolism, ER stress and microsomal cytochrome 
P450 reactions [89].  At physiological level, ROS can serve as signaling molecule 
involved in a variety of biological reaction including hormone and growth factor action 
[90], cell adhesion [91] and immune response [92]. However, high levels of ROS can 
oxidize DNA and lipids, generate irreversible oxidative modifications of proteins and 
persistently activate stress-sensing signaling pathways including mitogen-activated 
protein (MAP) kinase, c-Jun N-terminal kinase (JNK) and p38 MAP kinase [93], leading 
to apoptosis. In addition, high ROS can also impair mitochondrial membrane 
permeability, resulting in release of cytochrome c and apoptosis [94].  
1.4.2 Cellular sources for ROS production  
There are three main cellular sources of ROS production. The first one is NADPH 
oxidase (NOX). NOX is an enzyme that transfers electrons from NADPH to O2 to 
generate O2
- 
 [95]. The reaction by NOX2, which is also called “respiratory burst 
enzyme”, is most active in the plasma membrane of phagocytic cells to kill invading 
pathogens. A recent study suggests that most cells are able to generate intracellular ROS 
through NOX2 and other NOX isoforms [95]. For example, ROS can be generated by 
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NOX2 in skeletal [96] and cardiac muscle [97], NOX3 in hepatocytes [98] and NOX4 in 
adipocytes [99] in response to various hormones and fatty acids.  
The second source of ROS is mitochondria. Mitochondria generate ATP by 
consuming NADH or FADH2 through electron transport chain (ETC) and oxidative 
phosphorylation. In this pathway, electrons are transferred from NADH or FADH2 to 
oxygen through complex I to IV to produce a proton gradient, which drives ATP 
synthesis or heat production through uncoupling. Even under normal physiological 
conditions, ROS can be generated through electron leakage from ETC by incomplete 
transfer in mitochondria [100]. Main sites of mitochondrial ROS production are complex 
I and III [89]. When metabolic load is high, active fatty acid β-oxidation and glucose flux 
will generate more NADH and FADH2, resulting in greater ETC flux and proton gradient. 
If proton gradient cannot be dissipated by more ATP synthesis or heat production, 
electron leakage will increase significantly to generate more ROS. In addition, 
mitochondrial membrane dysfunction also increases the chance of electron leakage.  
The third source is ER. Enzymatic formation of disulfide bonds during protein 
folding in ER is estimated to account up to 25% of total ROS generation [101]. More 
details about this will be described in section 1.4.   
Besides these three main sources, peroxisome is also a potential source for ROS 
[102]. Fatty acid β-oxidation can also occur in peroxisomes especially for very long chain 
fatty acids. Because no ATP synthesis is coupled here, electrons are transferred to O2, 
yielding H2O2 instead of generating the proton gradient [49]. H2O2 is then converted by 
catalase into O2 and H2O. If generation of H2O2 exceeds the capacity of catalase, ROS 
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level will increase. Acyl CoA oxidase (ACOX) is the peroxisome specific enzyme to 
catalyze the first oxidation step, which can be used as the marker for peroxisomal β-
oxidation. 
1.4.3 Antioxidant response 
Antioxidant defense also plays an important role in redox homeostasis. Nuclear 
factor E2-related factor 2 (Nrf2) is a master transcription factor that regulates the 
antioxidant response. Under normal conditions, Nrf2 is rapidly degraded through Keap1-
mediated ubiquitin-dependent proteasomal pathway as well. If oxidative stress increases, 
several critical cysteine residues in Keap1will be disrupted, inactivating ubiquitination of 
Nrf2 [103]. In addition, Nrf2 is inactive due to cytoplasmic retention by kelch like-ECH-
associated protein 1 (Keap1). As a result, Nrf2 proteins accumulate in the nuclei and 
exert function. After translocating to the nuclei, Nrf2 can bind to antioxidant response 
element (ARE) in the promoter regions of downstream anti-oxidant genes, including 
NAD(P)H quinone oxidoreductase 1 (Nqo1), glutamate-cysteine ligase-catalytic subunit 
(Gclc), glutamate-cysteine ligase modifier subunit (GCLM), heme oxygenase 1 (HMOX1) 
and glutathione S-transferase (GST) [100], resulting in elevated expression of these genes 
and a more active antioxidant system.  
There are three major natural antioxidants inside the cells [100]: 1) exogenous 
small molecule antioxidants, such as lipoic acid, vitamin C and E, which act as reducing 
agents; 2) endogenous low-molecular-weight antioxidants, namely, glutathione 
(described more below); and 3) small protein antioxidants, namely, thioredoxin and 
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glutaredoxin that help reduction of other proteins by forming disulfide bonds and are then 
reduced by thioredoxin reductase and glutathione, respectively. 
Glutathione, a ubiquitous intracellular tripeptide (γ-L-glutamyl-L-cysteinyl-
glycine), is one of the major antioxidants. Glutathione exists in two forms: thiol-reduced 
form (GSH) and disulfide-oxidized form (GSSG). GSH can convert H2O2 to H2O by 
being oxidized to GSSG.  This reaction is catalyzed by glutathione peroxidase (GPX) in a 
selenium-dependent fashion. Also, GSH can reduce organic peroxides by GPX and GST. 
The resulting GSSG in turn can be reduced back to GSH by glutathione reductase (GR) 
using NADPH as cofactor to complete a redox cycle. GSH is particularly important in the 
mitochondria to reduce H2O2 because no catalase exists inside mitochondria [104]. The 
cellular ability to reduce GSSG to GSH can be overwhelmed under oxidative stress. In 
this case, accumulation of GSSG happens, leading to high GSSG/GSH ratios.  The excess 
GSSG can form a mixed disulfide (PSSG) by reacting with a protein sulfhydryl group 
(PSH) or be actively exported out of the cell to keep the intracellular redox equilibrium. 
As a result, cellular GSH will be eventually depleted under severe oxidative stress [105].  
Besides small antioxidant compounds, cells also use enzymatic reactions to 
defend against oxidative stress. They include SOD, catalase, glutathione reductase, and 
glutathione peroxidase, as mentioned above, as well as the following three enzymes.  1) 
GCLC is one of the two subunits of glutamate-cysteine ligase (GLC), which is the first 
rate limiting enzyme of glutathione synthesis. GCLC has been reported to be induced by 
oxidative stress [106]. 2) Heme oxygenase 1 (HMOX1) is an essential enzyme to degrade 
heme into biliverdin, which is rapidly reduced to bilirubin by biliverdin reductase. 
Bilirubin can be oxidized back to biliverdin again to form a redox cycle, suggesting that 
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bilirubin is a strong antioxidant [107]. HMOX1 has been shown to be important in 
preventing oxidative stress due to the fact that heme is required for the synthesis of 
redox-active heme proteins, many of which can generate ROS, such as P450 and those in 
mitochondrial complex I-IV [108; 109]. 3) Metallothionein (MT) can bind both 
physiological and xenobiotic heavy metals through the thiol group of cysteine residues, 
thus preventing these metals from being used in the Fenton reactions that generate 
hydroxyl radical [110]. In my studies, expression levels of most of these genes were 
determined to evaluate cellular oxidative stress.   
 
1.5 ER stress 
Endoplasmic reticulum (ER) is a subcellular organelle and its major functions 
include lipid or protein synthesis, protein folding and trafficking, and Ca
2+
 storage.  It has 
been reported that ER supported approximately one third of protein synthesis and 
modification for normal functions in a cell [111]. Also, ER provides a unique oxidizing 
environment for protein folding and modification. Only properly folded proteins are 
transported to the Golgi organelle. When unfolded or misfolded proteins accumulate in 
the lumen of the ER, the unfolded protein response (UPR), which is a major form of ER 
stress, will be activated.  
UPR induces ER-associated degradation (ERAD) of misfolded protein, protein 
folding, mRNA degradation, inhibition of mRNA translation and ER expansion to 
preserve the function of ER. BiP (binding immunoglobulin protein, also named as GRP78) 
is an ER chaperone protein for protein folding which also plays a key role in sensing and 
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regulating the UPR [112]. Under normal conditions, BiP binds to three UPR sensors: 
protein kinase-like endoplasmic reticulum kinase (PERK), inositol requiring protein 1α 
(IRE1α) and activating transcription factor 6 (ATF6). If ER stress is induced, some or all 
three of these sensors will be released from BiP and become activated. Once activated, 
IRE1α can splice the X-box binding protein 1 (XBP1) transcript to a spliced form, which 
encodes active XBP1a protein [113]. IRE1α/XBP1 signaling can activate a group of UPR 
genes, including chaperones, catalysts of folding, and ERAD genes to reduce ER stress. 
IRE1α also has RNase activity and degrades mRNAs to reduce the load of the ER [114]. 
Activated ATF6 can increase the induction of several UPR genes to catalyze the protein 
folding and degradation [115]. PERK, once activated, can phosphorylate its major 
substrate, eukaryotic initiation factor 2 α-subunit (eIF2α), to inhibit eIF2β activity and 
decrease the rate of most of mRNA translations [116; 117].  
Besides inhibiting the global translation to reduce the ER load, phosphorylation of 
eIF2α can increase the rate of translation of activating transcription factor 4 (ATF4). 
ATF4  is a transcription factor to induce expression of genes involved in ERAD, anti-
oxidative stress response, amino acid metabolism, ER oxidoreductin 1 (Ero1), NF-κB, 
growth arrest and DNA damage 34 (GADD34), and CCAAT/enhancer binding protein 
(CHOP) [112; 118; 119]. CHOP is important for ER stress induced cell death [120; 121; 
122]. Furthermore, Nrf2 is a downstream target for PERK [123], suggesting that ER 
stress and antioxidant capacity are functionally associated.  
All these UPR pathways can attenuate ER stress by decreasing the ER work load. 
However, when these pathways are overwhelmed, cell death will be induced, possibly via 
apoptosis [124]. Four possible apoptosis pathways are mediated by CHOP, JNK signaling, 
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Bax, and NF-κB [125-127], and all are activated by excess or prolonged ER stress and 
trigger apoptosis. 
 Oxidative formation of disulfide bonds is part of protein folding process and 
occurs in ER. It requires an oxidizing environment in the ER lumen in contrast to the 
reducing environment in cytosol [128]. When two cysteines form a disulfide bond, two 
electrons will be freed. They are first transferred to protein disulfide isomerase (PDI) , 
then to Ero1, and lastly to O2  to generate ROS [129]. A high demand for the processing 
of nascent proteins, especially those rich in disulfide bonds, such as insulin, increases 
ROS production in ER. It can be further exacerbated when GSH is consumed by protein 
disulfide isomerase mediated-refolding. Furthermore, Ca
2+
 can be released from ER, its 
major storage site, when ER is disrupted by ROS or ER stress. Since Ca
2+ 
can enhance 
TCA cycle and stimulate the release of cytochrome c from mitochondria, ER stress can 
cause greater ROS production in mitochondria through a more active ETC flux and the 
perturbation of ETC [130; 131]. On the other hand, oxidative stress may cause protein 
misfolding, which leads to ER stress. All these findings support the fact that ER stress 
and oxidative stress are tightly connected.   
 
1.6 Significance 
Our study of Ncb5or
-/- 
mouse model suggests that Ncb5or plays an important role 
in the utilization and metabolism of exogenous SFA and that Ncb5or protects cells from 
SFA-induced oxidative stress and cellular damage. Our study will provide a better 
understanding of the cellular mechanism of exogenous fatty acids, which will be applied 
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to the prevention and the treatment of lipotoxicity, diabetes, oxidative stress, and related 
diseases.  
 
1.7 Research questions 
 My main research goal is to fill the knowledge gap in our understanding of the 
role of Ncb5or in fatty acid metabolism and redox homeostasis.  
 Ncb5or
-/-
 mice receiving WT islet transplants display impaired fatty acid ∆
9 
desaturation in the livers at age 12 weeks, but the mechanism is unclear [36]. I will 
incorporate both prediabetic mouse model and primary hepatocytes to examine the role of 
Ncb5or in fatty acid metabolism. The functional relationship between Ncb5or and Cyb5A 
will be investigated in pilot experiments.  
 Ncb5or null hepatocytes have increased cell death under SFA treatment, possibly 
from increased ER stress, and the SFA cytotoxicity could be attenuated by co-treatment 
with MUFA [35; 36]. I will further investigate the underlying mechanism of how SFA 
causes Ncb5or
-/-
 hepatocyte death and how MUFA rescues the cells from cytotoxicity.  
My overall goal is to reveal the physiological function of Ncb5or and provide new 
knowledge for finding therapeutic targets or effective treatments to obesity and oxidative 
stress related diseases, including diabetes, atherosclerosis and neurodegenerative diseases. 
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The role of Ncb5or in fatty acid metabolism 
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2.1 Abstract 
The endoplasmic reticulum (ER)-associated NADH cytochrome b5 oxidoreductase 
(Ncb5or) is widely distributed in animal tissues. Ncb5or null mice develop diabetes at age 7 
weeks and have increased susceptibility to the diabetogenic agent streptozotocin. Ncb5or 
deficiency also results in lipoatrophy and increased sensitivity of hepatocytes to cytotoxic 
effects of saturated fatty acids. Here we investigate the mechanisms of these phenomena in 
prediabetic Ncb5or
-/- 
mice and find that, despite increased rates of fatty acid uptake and 
synthesis and elevated levels of expression of stearoyl-CoA desaturase (SCD), Ncb5or
 -/-
 
liver accumulates less triacylglycerol (TAG) than wild-type (WT). Ncb5or
-/-
 hepatocytes 
readily incorporate exogenous fatty acids into TAG but accumulate more free fatty acids 
(FFA). A high-fat diet rich in palmitate and oleate stimulates both lipogenesis and fatty acid 
catabolism in Ncb5or
 -/-
 liver, resulting in similar intracellular TAG levels but greater FFA 
accumulation compared to WT. In consideration of the 8-fold increase in Scd1 mRNA and 
protein levels, hepatic SCD specific activity is lower in Ncb5or
-/-
 mice than WT. Together, 
these findings suggest that increased FFA accumulation and catabolism are major 
consequences of Ncb5or
 
deficiency in liver. 
 
2.2 Introduction 
NADH-cytochrome b5 oxidoreductase (Ncb5or) is an endoplasmic reticulum 
(ER)-associated protein that has been implicated in lipid metabolism and diabetes. The 
Ncb5or null (KO) mouse model has two major phenotypes. These mice develop diabetes 
around 7 weeks of age with similar insulin sensitivity as WT [29].  
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Ncb5or KO mice also display lipoatrophy with significantly lower body weight 
and smaller white adipose tissues (WAT) than WT despite similar food intake [36]. The 
lipoatrophy was later found to be independent of diabetes and accompanied by impaired 
∆
9
 fatty acid desaturation in Ncb5or
-/-
 livers [36], indicating the role of Ncb5or in 
desaturation in vivo. The lipoatrophy phenotype is similar to the one in the SCD1 null 
mouse model that is lean and protected from obesity induced by a high-fat diet [41].  In 
addition, Ncb5or null hepatocytes were found to be more sensitive to SFA cytotoxicity, 
but not MUFA, by increased ER stress, apoptosis and cell death [35; 36]. Moreover, the 
SFA cytotoxicity and ER stress in these cells was attenuated by co-treatment with MUFA 
[35; 36]. Both in vivo and in vitro evidence led to the hypothesis that Ncb5or plays an 
important role in fatty acid desaturation pathway.  
Microsomal Cyb5A and Cyb5R3 serve as electron donors to ∆
9
 stearoyl-CoA 
desaturase (SCD) to facilitate the fatty acid desaturation in vitro [13-15]. However, 
mouse models with global or hepatic microsomal cytochrome b5 deficiency exhibit only 
mild or no ∆
9
 desaturation defect in the total lipids [25; 132], based on the evidence of 
similar SCD activity (unpublished data) and lipid profiles in the livers [132]. These 
findings strongly suggest that Cyb5A and Cyb5R3 are not exclusive electron donors for 
SCDs. Due to genetic similarity, functional property and more severe fatty acid 
desaturation defects in Ncb5or KO mice, we considered Ncb5or as an alternative electron 
donor for SCDs in vivo. 
To clarify the role of Ncb5or in fatty acid metabolism, we determined early 
molecular events in liver of prediabetic Ncb5or
-/-
 mice and employed primary 
hepatocytes to examine the metabolism of exogenous SFA in Ncb5or null cells. We also 
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used mouse models that lack Ncb5or or Cyb5A or both genes to dissect the different roles 
of Ncb5or and Cyb5A as electron donors for SCD in vivo. We find that, starting early in 
neonatal development, livers from Ncb5or null mice express higher levels of transcripts 
than WT for genes in fatty acid uptake, synthesis, activation and desaturation, as well as 
mitochondrial biogenesis, suggesting futile fatty acid cycling. Ncb5or
-/-
 hepatocytes 
accumulate more SFA in both TAG and FFA pools under SFA treatment, suggesting an 
important role of Ncb5or in fatty acid metabolism and ∆
9
desaturation pathway. 
 
2.3 Methods  
2.3.1 Mouse models  
 Ncb5or null mouse in BALB/cAnN strain was generated by deleting exon 4 of 
Ncb5or gene, which results in a non-functional truncated Ncb5or [29]. Ncb5or null 
mouse in C57BL/6 strain, obtained from Jackson laboratory, was generated using a 
strategy of outcross and then backcross to C57BL/6 for more than 10 generations. Ncb5or 
null and WT mice were generated from heterozygous crosses and maintained in a 
pathogen-free facility at 24°C under a standard 12 hour light and 12 hour dark cycle with 
free access to food and water.  
Hepatic b5 (Cyb5A) null mice (HBN) were generated by crossing albumin (ALB) 
Cre driver with Cyb5A floxed line, which was obtained from Dr. Roland Wolf [132]. We 
also generated a double knock-out (DKO) mouse model, which is deficient in Ncb5or 
(global) and Cyb5A (hepatic specific), through the following scheme. Ncb5or 
heterozygous (Ncb5or
 +/-
, b5 
+/+
) mice were first crossed with HBN mice (Ncb5or 
+/+
, b5 
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lox/lox
, Cre
ALB
) to generate first stage mice (Ncb5or
+/-
, b5
+/lox
, Cre
ALB
). Then by crossing 
within these first stage mice, male breeding mice (Ncb5or 
+/-
, b5
lox/lox
, Cre
ALB
) were 
generated and bred with female mice (Ncb5or 
+/-
, b5
lox/lox
) to generate DKO mice (Ncb5or 
-/-
, b5
lox/lox
, Cre
ALB
). Genotyping of WT and mutant alleles of Ncb5or and Cyb5A was 
performed by PCR with allele-specific primers (Figure 2.1). 
All the mice in my experiments were pre-diabetic male mice in C57BL/6 strain of 
age 4-5 weeks.  Blood glucose levels were measured to make sure that mice were non-
diabetic before use, unless otherwise indicated. The experimental protocol was approved 
by the Institutional Animal Care and Use Committee at the University of Kansas Medical 
Center.  Standard rodent chow (Purina 5015 from LabDiet, St. Paul, MN or TD 8604 
from Harlan Teklad, Madison, WI) was used in all studies, except the 10-day high-fat 
diet feeding protocol in which the high-fat diet (F5194 from BioServ, Frenchtown, NJ) 
was initiated immediately after weaning and continued for ten days. The 5015 chow diet 
contains 3.8 kcal/g, 11% fat content (by weight), and a composition of 33% SFA, 35% 
MUFA and 32% PUFA, all of which are in the form of TAG. The high-fat diet contained 
5.1 kcal/g, 35% fat by weight, anda composition of 40% SFA, 50% MUFA and 10% 
PUFA. Mice were sacrificed after 4-6 hours fasting, and plasma and tissues were 
collected, flash frozen in liquid nitrogen, and stored at -80
o
C until use. Glucose levels 
were measured using OneTouch Ultra glucometer (LifeScan, Milpitas, CA). 
2.3.2 Hepatocytes isolation and fatty acid treatment. 
Four week-old Ncb5or
-/- 
and WT mice were used for hepatocyte isolation after a 
3-4 hour fasting to minimize dietary effect. These mice were anesthetized using Avertin 
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Figure 2.1 Genotyping for livers of WT, HBN, Ncb5or
-/-
 and DKO mice by PCR. 
Genomic DNA was extracted from liver samples and PCR was performed to detect 
Ncb5or KO allele and cre-excised Cyb5A loxP allele. The products of KO and WT 
alleles in Ncb5or gene are 300-bp and 450-bp, respectively, as indicated by arrows. 
Primers for Cyb5A excised and non-excised loxP/loxP alleles generated around 800-bp 
and 500-bp products, respectively.  The weak Cyb5A WT bands in the liver samples from 
HBN and DKO mice indicated the existence of small percentage of non-hepatocytes cells 
in these liver samples.  The liver-specific excision of floxed exons 2-5 in Cyb5A is 
achieved through the use of a Cre transgenic line, whose expression is under the control 
of an albumin promoter. 
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 by IP injection (0.02ml/g). Then, the viscera of the mouse were exposed by making a 
ventral incision. A catheter (24g x 1” IV type, Fisher) was inserted into vena cava before 
perfusion.  The portal vein was severed immediately after the perfusion, and the thoracic 
vena cava was clamped. The perfusion speed was approximately 6 ml/minute. Mouse 
hepatocytes were isolated by a two-step perfusion procedure using Perfusion Solution I 
(0.5 mM EGTA, and 5.5mM glucose in HBSS) and Perfusion Solution II (1.5 mM CaCl2, 
5.5 mM glucose, with 0.0375% collagenase in HBSS), respectively.  
After isolation, hepatocytes were incubated at 37
o
 C in a humidified atmosphere 
(5% CO2, 95% air) in nutrient rich Williams’ medium E (Invitrogen,) containing 
penicillin /streptomycin, glutamine and 10% fetal bovine serum (FBS). Hepatocytes were 
plated into 6 well plates (Corning 3506) with 0.3 million cells per well, or into 96 well 
plates (Corning 3610) with 12,000 cells per well, or other plates with cell numbers 
mentioned below.  
 Fatty acids (in acid form) were complexed with bovine serum albumin (BSA) to 
avoid non-physiological toxic effects of free fatty acids during treatment. Palmitic acid 
(C16:0) and oleic acid (C18:1) were dissolved in 1M Tris-HCl (pH 8.0) with 2.1 mM 
FFA-free BSA [133]. The stock solution was first sonicated and then stirred in 37°C 
water bath overnight under nitrogen atmosphere to prevent oxidation.  The final molar 
ratio of fatty acid to BSA was lower than 4.  The fatty acid solution was adjusted to pH 
8.0 with NaOH, and filtered through a 0.2 µm filter. The final concentration of fatty acid 
was measured using a non-esterified fatty acid C kit (Wako Chemicals, Richmond, VA). 
All reagents were purchased from Sigma unless otherwise indicated.  
33 
 
2.3.3 RNA extraction and quantitative PCR 
RNA was extracted using Trizol (Invitrogen). Liver tissues were homogenized in 
Trizol for 5 seconds. For hepatocytes, Trizol were added into the wells immediately after 
I aspirated off the medium and then collected them into tubes. After brief vortexing and 
incubation at room temperature for 5-10 minutes, 0.2ml chloroform per ml Trizol was 
added into the tubes and were inverted  20 times to mix thoroughly. These tubes were sit 
at room temperature for 15-30 minutes for a good phase separation and then spun at 
12000g for 10 minutes at 4°C. To improve RNA quality, another run of chloroform 
extraction could be performed. After the phase separation, the clear supernatant was 
transferred into a new sterile tube and 0.5ml isopropanol per 1 ml Trizol was added to 
precipitate the RNA. After inverting tubes 20 times and incubating them at room 
temperature for 15 minutes, these tubes were spun at 12000g for 10 minutes at 4°C to 
collect RNA pellet. The pellet was washed with 70% ethanol once by a brief spin at 
9000g for 5 minutes at room temperature. After air-drying for 5 minutes at room 
temperature, RNA was resuspended with DEPC-water and ready for further analysis. The 
concentration of RNA was assessed by determining absorbance of UV light at 260 and 
280 nm wavelengths, with A260 for quantity (1 O.D. = 40 ng/l) and A260/A280 ratio for 
quality (optimal ratio = 1.8).  
Two µg of RNA was reverse transcribed to cDNA using M-MLV (Moloney 
Murine Leukemia Virus) Reverse Transcriptase kit (Invitrogen). Total volume of each 
reaction was 50µl, containing 400 µM dNTP, 100 ng Random Primer, 4 mM DTT, 25 U 
RNASE OUT and 125 U M-MLV. The reaction was incubated at 42°C for 15 minutes 
and then heated at 95°C for 5 minutes in the PCR thermal cycler to deactivate the enzyme. 
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After reverse transcription, cDNAs were diluted 10 times and prepared for further 
analysis.  
Quantitative PCR (q-PCR) was performed using Power SYBR Green PCR Master 
Mix (Applied Biosystems) in a 384 well plate. Each reaction had 10 µl in volume and 
contained 5µl master mix, 0.6 µM each primer, and 2 µl diluted cDNA.  All reactions 
were performed in duplicate for 40 cycles with a two-step protocol (92°C for 15 seconds 
and 60°C for 1 minute) on a Prism 7900 Sequence Detection System (Applied 
Biosystems).  
The sequences of primers were either adopted from literature or designed by 
Primer Express 2.0 or primer-BLAST from NCBI. In the latter, parameters for primer 
designing are: melting temperature is between 58-60°C; one primer from each set has to 
span two neighboring exons to avoid recognizing genomic DNA, and the length of 
product is between 100-200 bp for optimal amplification efficiency. The level of each 
target mRNA was calculated by using comparative CT method, which determines the 
amount of target after normalization to an endogenous reference, 18S ribosomal RNA 
(18S) in our cases. The reasons for choosing 18S are: 1) 18S is a house-keeping transcript 
and does not vary too much between different treatments; 2) 18S expresses in nearly all 
tissues and cells; 3) 18S produced a good linear standard curve (R
2
=0.9978) using 
different dilutions of cDNA. Potential complications of high expression levels of 18S 
could be solved by adjusting the baseline setting to reach a linear response range.      
2.3.4 Immunoblot Analysis 
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 Small pieces (around 50 mg) of mouse livers were homogenized in lysis buffer (25 
mM HEPES, 50 mM KCl, 6% glycerol, 5 mM EDTA, 5 mM EGTA, 0.5% Triton-X100, 50 
mM NaF, 40 mM glycerol phosphate, and 25 mM sodium pyrophosphate) with inhibitors of 
phosphatases (PhosSTOP from Roche, Indianapolis, IN) and proteases (SigmaFAST from 
Sigma, St. Louis, MO).  The lysate was then cleared by centrifugation (16,000g, 10 min, 
4°C). Total protein content was determined with Commassie Plus reagents (Pierce, Rockford, 
IL). Proteins (around 50 µg) were loaded into each lane on a 4-15% gradient SDS-PAGE gel. 
Signals were developed with horseradish peroxidase (HRP)-conjugated secondary 
antibodies and SuperSignal West Pico Chemiluminescent Substrate (Pierce). The Adobe 
Photoshop software was used to quantify intensity of signals.  
2.3.5 Lipid profiling and total content assay 
 Lipids from hepatocytes and frozen liver tissues were extracted using the Folch 
method. For cultured hepatocytes, cells were washed with room temperature PBS three 
times and scraped them off from the plates into 500 µl ice-old lysis buffer containing 18 
mM Tris-HCl, 300 mM Mannitol, 50 mM EGTA, pH 7.6, with 5 mM 
phenylmethanesulfonyl fluoride (PMSF). Two 6-wells of the cells (~0.5 million) were 
combined and used for each assay. The cell suspensions were sonicated for 10 one-
second pulses with a micro-tip to lyse the cells.  For frozen liver tissues, 50-100 mg of 
liver was homogenized in 1 ml lysis buffer for each assay. Twenty to 30 µl cell lysate 
were taken out for measurement of protein concentration, and the rest were added into 
2ml methanol with butylated hydroxytoluene (BHT, 0.05% v/v, to prevent the oxidation 
of the fatty acid during the extraction) and 4 ml chloroform in the glass tubes (4 ml 
methanol with BHT and 8 ml chloroform were used for liver tissues).  
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 To minimize random errors during sample processing and to serve as internal 
standards for quantification, heptadecanoic acids in TAG and FFA forms (C17:0, non 
detectable in animal fat) were added into samples as internal controls before lipid 
extraction. For hepatocytes, 1 nmole C17:0 TAG, 5 nmole C17:0 PL and 3 nmoles C17:0 
FFA were added to each sample. For liver tissues, 50 nmole C17:0 TAG, 50 nmole C17:0 
PL and 100 nmole C17:0 FFA were added to each sample. All lipid work was performed 
with clean glass tubes with Teflon-lined caps.  These tubes were vortexed for 10 seconds 
and rotated for 4 hours to overnight.  After the rotation, 0.8 ml 0.15M KCl (1.6 ml for 
liver tissues) was added into each tube, which was then vortexed for 10 seconds. For liver 
tissues, before the addition of KCl, the mixture was filtered through a funnel lined with 
filter paper (Whatman #1) into a new clean glass tube to get rid of precipitates. These 
tubes were then centrifuged at 500 r.p.m for 5 minutes for phase separation. After the 
centrifuge, the bottom phase (organic) was carefully transferred with a glass Pasteur 
pipette to a new glass tube and evaporated under a nitrogen stream in a 35°C water bath 
to result in lipid pellets.  
For the assay of total content of TAG, nonesterified fatty acid, free cholesterol, 
cholesterol ester and total lipids from livers or plasma, lipid pellets were resuspended 
with 10% Triton X-100 in isopropyl alcohol and directly measured by colorimetric kits 
from Sigma or Wako Chemicals. 
For further separation of lipid species through thin layer chromatography (TLC), 
each lipid pellet was dissolved in 50-100 µl dichloromethane (200 µl or more for liver 
tissues). The mixture was spotted onto silica gel plates, which were pre-dried in 100°C 
oven for 1 hour. Standards, such as ~10 nmole C17:0 in FFA, TAG and PL forms, were 
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spotted to serve as markers for each band. The plate was placed in a sealed glass chamber 
containing 80:20:1 mixture of hexane: ether: acetic acid lined with a piece of Whatman 
#1 filter paper. After the solvent ran to the top of the plate, the plate was taken out and 
sprayed with a fluorescent whitening agent (0.1g/L 2,5-Bis (5-tert- butyl-benzoxazolyl)-
thiophene (BBOT, in chloroform/methanol (1:1; v/v)). Under a UV-light, each separated 
lipid group was visualized according to the position of markers.   The silica gel 
containing the lipid of interest was excised with a single edge razor blade and then 
transferred into a new glass tube.  
Transmethylation was performed to prepare fatty acid methyl esters (FAMEs) that 
are non-reactive and more volatile derivatives of fatty acids. For TAG, a mixture of 0.5 
mL BF3, 0.4 mL Benzene and 1.1mL methanol was added to each sample, and the tubes 
were filled with nitrogen to prevent oxidation during the transmethylation. These tubes 
were then placed in a dry heat block at 100°C for 30 minutes. Every two minutes or so, 
the caps were tightened to prevent leakage. At the end of this treatment, these tubes were 
immediately placed into ice. After they were cooled down, 2 mL H2O and 4 mL pentane 
were added to each tube, and the mixture was vortexed for 1-2 minutes to extract FAMEs. 
After centrifuging for 5 minutes at 500 r.p.m, the upper pentane phase was transferred 
with a Pasteur pipette to a Varian 2 mL glass vial with a Teflon-lined cap and was 
concentrated under a stream of nitrogen. After the lipids were dry, 20µl dichloromethane 
(100µl for liver tissues) were added to dissolve these lipids. After vortexing, these lipids 
were ready for analysis as below.  
GC-MS (Gas chromatography-mass spectrometry) was used for lipid analysis . 
The system contained a GC450 with MS220 from Varian (Palo Alto, CA), which used a 
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100m x 0.25mm Varian FAME Select CP 7420 (df 0.39µm) column. The setting of 
temperature gradient was: 140°C hold for the initial 5 minutes, then increased to 240°C at 
a speed of 4°C per minute, and then 240°Chold for 11 minutes. The total time for each 
run was 41 minutes. The temperature settings for MS were 220°C for trap, 80°C for 
manifold and 250°C for transferline. The injector temperature was set at 260°C.  Supelco 
37 component FAME mix standards (Sigma: St. Louis, MO) was used to confirm all 
FAMEs that were identified in our studies. In addition to elution time, mass spectrum of 
each FAME peak was also used for identification.  
Total ion current (TIC) was used to calculate the absolute amount of each FAME, 
which was normalized against the C17:0 internal control at a later time. Most of FAMEs 
in cell or tissue lipids contain a lot of noise when being calculated by the TIC.  Therefore, 
ten most specific and abundant ions of each FAME species were counted to improve the 
specificity and accuracy. The sum of these ten ions was then divided by a response factor 
to generate the total ion current for each FAME species. Response factors were calculated 
by dividing the sum of ten specific ion currents by the sum of total ion currents from the 
Supelco 37 standards. The total fatty acid amount for each lipid sample was calculated by 
the sum of absolute amount of all identified FAME species.  
2.3.6 Stearoyl-CoA Desaturase (SCD) activity assay 
 SCD activity was determined by using [
14
C] stearoyl-CoA substrate (American 
Radiolabeled Chemicals, St. Louis, MO) as described [134]. Briefly, microsomes were 
isolated from mouse livers and purified on a continuous density gradient [6]. Fifty µg 
microsomal proteins were mixed with 2 nmol [
14
C] stearoyl-CoA and 1 µmol NADH in 0.1 
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mM Tris-HCl (pH 7.0) and incubated at 37°C for 5 min.  Total lipids were extracted and 
transmethylated as above to yield FAME.  Radiolabeled substrates (C18:0) and products 
(C18:1) were separated by TLC on silica gel plates containing 10% AgNO3 (Analtech, 
Newark, DE). Each plate was air dried and exposed to a phosphor imager.  Signals were 
stored and quantitated with a Molecular Imager Pro Plus with Quantity One software (Bio-
Rad, Hercules, CA).  Counts were used to calculate the yield [(C18:1)/(C18:0+C18:1)], 
which was then converted to SCD activity (nmol/min./mg).  All reactions followed linear 
(first order) kinetics under the above conditions. 
2.3.7 Data analysis 
 One-way analysis of variance (ANOVA) was used to detect the significant 
difference within and between groups. A value of p<0.05 was considered statistically 
significant. Data are presented as the mean ± standard error of the mean (S.E.). 
 
2.4 Results 
2.4.1 Altered lipid metabolism in livers of Ncb5or 
-/- 
mice 
 Microarray analyses of RNA samples from mouse liver suggested that 5-week-old 
Ncb5or 
-/- 
mice had elevated expression levels of lipid metabolism genes compared to 
WT.  This result was further confirmed by quantitative RT-PCR (Table 2.1). These genes 
included (1) SCD1 and SCD2 (fatty acid desaturation); (2) FAS (fatty acid synthesis); (3) 
PGC1α (mitochondrial biogenesis); (4) CD36 and LPL (fatty acid uptake) and (5) one 
isoform of ACSL, ACSL3 (fatty acid activation).  
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To further examine the temporal progression of expression of these genes in the 
livers, quantitative RT-PCR was used to measure the transcript levels of these genes in 
the livers of WT and Ncb5or 
-/- 
mice in newborn and at age 2, 3 weeks (Table 2.1).  We 
observed significantly higher levels of SCD1, SCD2, FAS and ACSL3 transcripts in 
Ncb5or 
-/- 
liver than WT at all ages except 3 weeks. The expression of SCD2 is at the 
highest level in newborn stage whereas SCD1 starts at age 3 weeks as reported previously 
[38]. Both hepatic SCD1 and SCD2 were up-regulated by at least 2 fold in Ncb5or 
-/- 
mice at all ages except for 3 weeks, at which time a transition from SCD2 to SCD1 
occurs in the liver. The increased hepatic SCD1 and SCD2 expression might be due to the 
compensation for the deficiency of fatty acid desaturation, which was further examined 
below. ACSL3 is more involved in catabolism than anabolism [73].  Other ACSL 
isoforms displayed no difference between the two genotypes (data not shown).The 
hepatic expression level of CD36, LPL and PGC1α were higher in Ncb5or 
-/- 
mice than 
WT only at age 3 and 5 weeks, suggesting that the different response may be related to 
exposure to diet, since mice start to ingest diet at this age. 
We did not detect any difference for hepatic expression level of GPAT1, GPAT4, 
LIPIN and DGAT2 at 5 weeks between WT and Ncb5or 
-/- 
mice (data not shown). This 
suggests that the phospholipid and TAG synthesis in Ncb5or 
-/- 
mice is not impaired and 
that defect in fatty acid metabolism is limited to fatty acid desaturation and synthesis. 
Likewise, hepatic PPARα, PPARγ, PPARδ/β remained the same in WT and Ncb5or 
-/- 
mice (data not shown), indicating that the deficiency is not sufficient to induce the 
transcription of these nuclear receptor genes.  
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In summary, we observed increased gene expression levels in all of the following 
pathways: de novo lipogenesis (SCD1, SCD2, FAS), fatty acid uptake (LPL and CD36), 
fatty acid activation/catabolism (ACSL3), and mitochondrial biogenesis (PGC1α). This 
suggests that liver of Ncb5or
-/-
 mice has increased fatty acid synthesis in parallel to 
elevated catabolism, suggesting futile fatty acid cycling, similar to that described in 
thiazolidinediones (TZDs) treated adipocytes [135].   
 
2.4.2  Reduced hepatic TAG content and impaired fatty acid desaturation in                            
Ncb5or 
-/- 
 mice 
To determine whether altered gene expression pattern resulted in lipid 
abnormality, we examined the lipid profile of hepatic TAG from WT and Ncb5or 
-/- 
mice 
at different ages.  
We found that the three most abundant fatty acid substituents in hepatic TAG are 
palmitate (C16:0), oleate (C18:1n9c) and linoleate (C18:2n6c) at age 3 weeks (Figure 
2.2). Compared to WT, Ncb5or 
-/- 
mice had significantly less C16:0, C18:1n9c, 
palmitoleate (C16:1n7c) and C18:1n7c (the elongated product from C16:1n7c) in hepatic 
TAG pool whereas most of the other SFA and PUFA content remained the same. C16:0 
is the principal product of FAS in de novo lipogenesis and can be elongated to C18:0. 
These SFA can be converted to their corresponding MUFA, C16:1n7c and C18:1n9c, 
respectively, through ∆
9
 desaturation pathway by SCD. This piece of data suggested that 
liver of Ncb5or 
-/- 
 mice had impaired ∆
9
 desaturation, but not ∆
5
, ∆
6 
that are required for 
PUFAs. 
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Table 2.1 Transcript levels of genes involved in lipid metabolism and mitochondrial 
biogenesis in newborn, 2-, 3-, 5-week-old Ncb5or
-/-
 and WT mouse livers.  
Quantitative PCR was used to detect the relative mRNA levels of genes in lipid 
metabolism in WT and Ncb5or
-/-
 RNA samples. The level of averaged WT sample was 
arbitrarily defined as 1 to allow comparison for each target gene. All values are mean ± 
S.E. (n=6) and relative to 18S (×10
6
). 
a
p<0.05, 
b
p<0.01, 
c
p<0.005. The transcript levels in 
bold form indicate the significant difference. 
SCD: Stearoyl-CoA desaturase; FAS: Fatty acid synthase; PGC1α: Peroxisome 
proliferator-activated receptor gamma coactivator-1 α; CD36: Cluster of Differentiation 
36; LPL: Lipoprotein lipases; ACSL: Long-chain fatty acid-CoA ligases 
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Figure 2.2 Fatty acid composition of hepatic TAG from 3-week-old chow-fed 
Ncb5or
-/-
 and WT mice. Fatty acid composition of hepatic TAG was determined by GC 
analysis. Results were obtained from 6-8 animals (n=6-8) in each experimental group and 
expressed as mean ± S.E. *, p<0.05. White-bar: WT; Black-bar: Ncb5or
-/-
.  Dr. WenFang 
Wang fully contributed to this figure. 
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To better represent the activity of ∆
9
 desaturation pathway in the liver, we 
calculated the ratio of C16:1n7c to C16:0 as the desaturation index for 16 carbons (DI, 
C16), and the ratio of C18:1n9c to C18:0 as the desaturation index for 18 carbons (DI, 
C18), for the profiles of hepatic TAG in 3, 5 and 12 weeks old mice (Figure 2.3 B, 2.3 C). 
In addition, we calculated the total hepatic TAG content by the sum of all fatty acid 
substituents (Figure 2.3A).  
We found that hepatic TAG content in Ncb5or 
-/- 
mice was lower than WT at all 
ages we examined. The difference of TAG content is at the biggest at age 12 weeks, 
which is caused by the combination of lipoatrophy and the onset of diabetes. All of the 
desaturation indices (DI) were significantly lower in hepatic TAG of Ncb5or 
-/- 
mice than 
those in WT with only one exception, i.e., DI of C16 at age 5 weeks. It is likely 
contributed by the higher expression levels of SCD1 and SCD2 in Ncb5or 
-/- 
liver than 
WT at this age (Figure 2.1), although DI of C18 remained lower in Ncb5or 
-/- 
liver. The 
decreased desaturation indices in prediabetic Ncb5or 
-/- 
mice are consistent with our 
previous findings in TKO mouse [36], suggesting that Ncb5or 
-/- 
mice are impaired in ∆
9
 
fatty acid desaturation.  
There are three potential causes for the diminished hepatic TAG contents in 
Ncb5or 
-/- 
mice. The first one is that more hepatic TAGs are secreted into circulation and 
then taken up by other tissues. To examine this possibility, we measured the total content 
of TAG, nonesterified (free) fatty acid, free cholesterol and cholesterol ester in the sera of 
WT and Ncb5or 
-/- 
mice. Similar level of these lipids in the circulation (Table 2.2) 
excludes the increased excretion as the cause.  
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Figure 2.3 Hepatic TAG content of chow-fed Ncb5or
-/-
 and WT mice. Fatty acid 
compositions of hepatic TAG from 3-, 5- and 12-week-old mice were determined by GC 
analysis.  Values were used to calculate hepatic TAG level (A) and desaturation index 
(DI) of 16:1/16:0 (B) and 18:1/18:0 (C) at all three ages. Results were obtained from 6-14 
animals (n=6-14) in each experimental group and expressed as mean ± S.E. *, p<0.05. 
White-bar: WT; Black-bar: Ncb5or
-/-
. Dr. WenFang Wang performed analyses of all 
samples except those at age 5 weeks. More samples were included in the 5-week-old 
mouse group, resulting in a more accurate result in this figure than that recently reported 
in [136].  
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Table 2.2 Body weight and plasma lipid parameters of chow-fed 2-, 3-, and 5-week-
old Ncb5or
-/- 
and WT mice. Total content of TAG, free fatty acid (FFA), free 
cholesterol, and cholesterol ester were directly measured by colorimetric kits. Results 
were obtained from more than 7 animals (n>7) in each experimental group and expressed 
as mean ± S.E.   
a
p<0.01, 
b
p<0.05.  n ≥ 7 in all cases.   
Dr. WenFang Wang fully contributed to this table. 
 
Genotype 
Age  
(week) 
Body 
Weight  
(g) 
TAG  
(mg/dL) 
FFA  
(mM) 
Free 
Cholesterol  
(mg/dL) 
Cholesterol 
ester 
(mg/dL) 
WT 2 6.96+0.15 47.0+9.4 1.29+0.07 106.0+4.4 33.9+4.6 
Ncb5or
-/-
 2 6.07+0.24
a
 93.3+17.8 1.72+0.09 123.6+10.2 47.2+11.1 
WT 3 9.17+0.31 79.4+11.8 1.60+0.09 70.4+3.5 44.5+4.5 
Ncb5or
-/-
 3 7.55+0.16
 a
 57.3+8.9 1.48+0.26 91.5+6.5 54.8+5.8 
WT 5 20.27+0.53 75.7+7.0 1.50+0.09 92.6+3.4 22.2+3.8 
Ncb5or
-/-
 5 17.67+0.83
 b
 101.2+12.9 1.40+0.03 91.9+6.5 25.2+7.2 
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The second one is that hepatic TAG synthesis is deficient in Ncb5or 
-/-
 mice. 
However, no difference was observed in hepatic transcript levels of DGAT2, GPAT1 and 
GPAT4 in these mice (data not shown). In addition, isolated WT and Ncb5or 
-/- 
hepatocytes incorporated exogenous fatty acid into the TAG pool at a similar rate as WT 
(data shown below), suggesting that hepatic TAG synthesis remained intact in Ncb5or 
-/-
 
mice.  
The third one is that, due to the deficiency in SCD desaturation, more saturated 
fatty acids are accumulated and catabolized through β-oxidation than those being 
converted into MUFA and incorporated into TAG. Increased fatty acid 
activation/catabolism (ACSL3) and mitochondrial biogenesis (PGC1α) in the livers from 
Ncb5or 
-/- 
mice (Table 2.1), indicating that this is likely the cause. Functional studies 
supporting this possibility are described in the next chapter.  
2.4.3 Increased accumulation of palmitate in the intracellular TAG and FFA pools of 
Ncb5or 
-/- 
hepatocytes upon short term incubation of palmitate 
 We next studied the metabolism of exogenous SFA in isolated primary 
hepatocytes from pre-diabetic Ncb5or 
-/- 
mice at age 4-5 weeks. The use of cell system 
allows us to avoid effects (cross-talks) from other tissues, as well as diets and factors 
related to animal physiology.  
We treated WT and Ncb5or 
-/- 
hepatocytes with BSA (vehicle control) or 
palmitate (C16:0) or oleate (C18:1) or both for 8 hours. We chose palmitate and oleate 
because they are the most abundant form of SFA and MUFA in animal tissues, 
respectively. Under our experimental conditions, more than 85% of Ncb5or 
-/- 
48 
 
hepatocytes survived after SFA treatment  (see Chapter 3), and more than 0.05 mM fatty 
acids remained in the media after 8 hours of treatment (data not shown), indicating no 
starvation of nutrient in these cells.  
Under C16:0 or C18:1 treatment, a rise of total TAG content occurred in Ncb5or
-/- 
and WT hepatocytes compared to the BSA-treated cells, and no difference was observed 
between the two genotypes under either condition (Figure 2.4A).  This finding is 
consistent with the fact that transcript levels of genes in TAG synthesis did not differ 
between the two genotypes (Figure 2.5), suggesting that Ncb5or
-/- 
hepatocytes have intact 
TAG synthesis.  
After 8 hours of C16:0 treatment, Ncb5or
-/- 
hepatocytes exhibited ~1.6 fold lower 
C16:1/C16:0 ratio of the TAG pool than that in WT cells (Figure 2.4 A). Because 
transcript levels of SCD1 and SCD2 in Ncb5or
-/- 
cells were similar to those in WT 
(Figure 2.5), over-abundance of C16:0 and the resulted TAG remodeling in Ncb5or
-/- 
hepatocytes reflects their deficiency in converting exogenous SFA to MUFA , rather than 
altered TAG synthesis. Under the treatment with C18:1, WT and Ncb5or
-/- 
hepatocytes 
had similar DI (C18:1/C18:0) values of intracellular TAG (Figure 2.4 A), suggesting that 
metabolism of MUFA remained intact in Ncb5or
-/- 
hepatocytes. This conclusion is further 
supported by co-incubation with both C16:0 and C18:1, which abolished the difference of 
DI (C16) between genotypes and led to an even higher TAG content in Ncb5or
-/- 
hepatocytes than WT (Figure 2.4 A).   
 In addition to changes in intracellular TAG, Ncb5or
-/- 
hepatocytes displayed 
significantly higher levels of intracellular FFA, especially SFA, under basal (untreated) 
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and C16:0 treatment compared to WT cells (Figure 2.4 B, Figure 2.6 B). One explanation 
is that these SFAs were not converted into MUFAs that were preferred substrates for 
TAG synthesis and remained as intracellular FFA in Ncb5or
-/- 
hepatocytes,  instead of 
being esterified into the TAG pool. Incubation with C18:1alone seemed to abolish the 
difference, whereas co-incubation with C16:0 and C18:1 totally abolished the difference 
in intracellular FFA levels between genotypes (Figure 2.4 B).  
 The metabolic fate of palmitate in in Ncb5or
-/- 
hepatocytes under these treatments 
is illustrated in Figure 2.6.  These cells accumulate more C16:0 in the FFA pool at basal 
level compared to WT cells and the amount of C16:0 further increased after C16:0 
treatment. Co-incubation with both C16:0 and C18:1 significantly decreased the level of 
free C16:0 in Ncb5or
-/-
 hepatocytes compared to C16:0 treatment alone (Figure 2.6 B), 
indicating an active metabolism of C16:0 in these cells. In TAG pool, we observed that 
C16:0 treatment alone increased more C16:0 amount in Ncb5or
-/-
 hepatocytes than that in 
the WT cells and co-incubation with both C16:0 and C18:1 further increased the C16:0 
amount (Figure 2.6A).  The fact that co-incubation increased C16:0 amount in TAG but 
decreased C16:0 amount in FFA suggests that C18:1 helped to channeled C16:0 to TAG 
synthesis from the intracellular FFA pool as previously reported [54].  
 Unlike the TAG pool (Figure 2.4A), intracellular FFA (Figure 2.4B) and 
phospholipid pools (Figure 3.5) displayed no significant difference in DI of C16 and C18 
between Ncb5or
-/- 
and WT hepatocytes under all treatments.     
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Figure 2.4 Increased accumulation of palmitate in the intracellular TAG and FFA 
pools in Ncb5or
-/- 
hepatocyte upon short term incubation of palmitate. Hepatocytes 
were isolated and treated with palmitate or oleate or BSA carrier alone. Intracellular FFA 
and TAG were prepared and analyzed for determination of lipid profiles by GC/MS. The 
total content, desaturation index of C16:1/C16:0 and C18:1/C18:0 were determined for 
TAG (A) and FFA (B). Results were obtained from 4-6 animal-pairs (n=4-6) for TAG 
and FFA profiling and expressed as mean ± S.E. *, p<0.05. White-bar: WT; Black-bar: 
Ncb5or
-/-
. 
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Figure 2.5  Effects of fatty acid incubation on the expression of genes in fatty acid 
desaturation and TAG synthesis in Ncb5or
-/-
 and WT hepatocytes. Hepatocytes were 
isolated and treated with palmitate or oleate or BSA alone (vehicle control). Total RNAs 
were collected and used for quantitative RT-PCR. Results were obtained from 3-5 
animal-pairs (n=3-5) and expressed as mean ± S.E. *, p<0.05.  White-bar: WT; Black-
bar: Ncb5or
-/-
. 
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Figure 2.6 Fate of palmitate under incubation and co-incubation with palmitate and 
oleate in Ncb5or
-/- 
hepatocytes.  Hepatocytes were isolated and treated with palmitate or 
oleate or BSA carrier alone. Intracellular FFA and TAG were prepared and analyzed for 
determination of lipid profiles by GC/MS. Palmitate (C16:0) levels were determined in 
TAG (A) and FFA pool (B). Results were obtained from 4-6 animal-pairs (n=4-6) for 
TAG and FFA profiling and expressed as mean ± S.E. *, p<0.05. White-bar: WT; Black-
bar: Ncb5or
-/-
. 
 
 
 
A 
B 
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2.4.4 High fat diet stimulated lipogenesis and fatty acid catabolism in Ncb5or
-/-
 livers 
 We observed that co-incubation with C16:0 and C18:1 resulted in a higher TAG 
content in Ncb5or
-/- 
hepatocytes than WT. We next investigated whether the rescue can 
take place in whole animals. We fed WT and Ncb5or
-/- 
mice a high fat (HF) diet rich in 
SFAs and MUFAs. BecauseNcb5or
-/- 
mice develops diabetes around 7 weeks [29], we 
decided to start HF feeding at age 3 weeks, right after weaning. After 10 days on HF, 
Ncb5or
-/- 
mice maintained lower body weight compared to WT (data not shown), similar 
to chow-fed counterparts (Table 2.2). However, we found that HF intervention fully 
restored the hepatic TAG content in Ncb5or
-/- 
mice (Figure 2.7B), consistent with our 
findings in hepatocytes. Compared to WT, Ncb5or
-/- 
mice displayed significantly higher 
levels of intracellular free fatty acids (1.2-fold, Figure 2.7 A), higher DI values for C16 
(2.0-fold, Figure 2.7 C) and C18 (1.3-fold, Figure 2.7 D) fatty acid substituents of hepatic 
TAG. These changes in DI, however, were not observed in Ncb5or
-/- 
hepatocytes under 
co-incubation of C16:0 and C18:1.  
To understand the mechanism of increased hepatic TAG synthesis in Ncb5or
-/- 
mice, we measured transcript levels of key enzymes in hepatic lipid metabolism.  We 
found a much bigger fold increase in the expression level of these enzymes in Ncb5or
-/- 
mice (Table 2.3).  The higher transcript levels of SCD1 (9.2-fold) and Cyb5A (1.2-fold) 
correlated to the higher DI values in Ncb5or
-/- 
livers. Higher transcript levels of genes in 
phospholipid/TAG synthesis, such as GPAT1 (2.3-fold), GPAT4 (2.9-fold), LIPIN (9.0-
fold) and DGAT2 (2.3-fold), suggested that elevated levels of key enzymes and over-
abundance of fatty acid substrates are responsible for restored hepatic TAG levels in 
Ncb5or
-/- 
mice. In addition, Ncb5or
-/- 
liver displayed 7-fold higher levels of fatty acid 
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synthase (FAS) transcripts, which correlated to their higher levels of intracellular FFA 
than WT.  
Primary hepatocytes of Ncb5or
-/- 
mice under the co-incubation of SFA and 
MUFA displayed no change in expression of fatty acid desaturation and synthesis 
enzymes (Figure 2.6).  This is differed from livers of whole animals fed with HF, 
suggesting that these changes in hepatocytes may be stimulated by cross-talk with other 
tissues. Besides these genes, we observed higher transcript levels of enzymes involved in 
∆
6
 fatty acid desaturation (FADS2, 5.5-fold), fatty acid uptake (LPL, 4.5-fold, and CD36, 
2.3-fold), mitochondrial biogenesis (PGC1, 2.9-fold), fatty acid activation (ACSL1, 
ACSL4 and ACSL5, 1.3-2.7 fold) and their upstream nuclear receptor regulator 
(PPARfold and PPARβ/ 3.3-fold). All these changes suggested a more active 
lipogenesis and fatty acid catabolism in Ncb5or
-/-
 liver in response to HF diet than that 
with chow.   
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Figure 2.7 Effects of 10-day high-fat feeding on hepatic lipid content of Ncb5or
-/-
 
and WT mice. After 10 days on a high-fat diet, the amount of hepatic lipids as FFA (A) 
and TAG (B) from 4.5-week-old WT (n=9) and Ncb5or
-/-
 (n=6) mice was determined by 
colorimetric assay and GC-MS, respectively.  Desaturation indices of hepatic TAG are 
plotted for 16:1/16:0 (C) and 18:1/18:0 (D).  Results are expressed as mean ± S.E. *, 
p<0.05. White-bar: WT; Black-bar: Ncb5or
-/-
. I helped with lipid analysis and Dr. 
WenFang Wang contributed to the rest of this Figure. 
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Table 2.3 Transcript levels of genes involved in lipid metabolism in 4.5-week-old 
Ncb5or
-/-
 and WT mouse livers after 10-day high-fat feeding.  All values are mean ± 
S.E. (n=6) and relative to 18S (×10
6
). 
a
p<0.05, 
b
p<0.01, 
c
p<0.005. 
 
 WT Ncb5or
-/-
 Fold ↑ in Ncb5or
-/-
 
SCD1 103±12 947±158
c
 9.2 
SCD2 1.23±0.11 1.75±0.25 1.4 
FADS2 26.4±4.3 144±27
c
 5.5 
GPAT1 19.6±1.8 45.2±7.0
c
 2.3 
GPAT4 5.69±1.04 16.3±2.2
c
 2.9 
LIPIN 2.2±0.5 19.8±4.7
c
 9.0 
DGAT2 52.5±4.4 121±17
c
 2.3 
Cyb5A 353±9 432±18
c
 1.2 
FAS 3.19±0.41 21.4±5.4
c
 6.7 
PGC1α 3.56±0.64 10.4±1.3
c
 2.9 
PPARα 11.2±1.2 28.4±2.8
c
 2.5 
PPARβ/δ 0.29±0.05 0.97±0.14
c
 3.3 
ACSL1 31.2±3.1 41.9±1.7
a
 1.3 
ACSL3 0.83±0.13 2.03±0.29
c
 2.4 
ACSL4 4.35±0.51 6.45±0.71
a
 1.5 
ACSL5 5.72±0.42 15.2±1.7
c
 2.7 
CD36 6.11±0.52 14.2±2.3
c
 2.3 
LPL 10.2±0.6 45.6±6.7
c
 4.5 
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2.4.5 Decreased SCD specific activity in Ncb5or
-/-
 liver microsomes 
 Based on studies described above, we conclude that Ncb5or plays an important 
role in fatty acid ∆
9
 desaturation pathway. However, the exact mechanism through which 
Ncb5or regulates this pathway still remains unclear. Based on the structural similarity 
betweenNcb5or and the Cyb5A/Cyb5R3 pair, it is plausible that Ncb5or may function as 
an alternative electron donor for SCD in ∆
9
 desaturation.  
 We next determined whether the lack of Ncb5or would affect SCD activity. The 
classic in vitro reconstitution assay would include substrates (SFA), purified or enriched 
enzymes (SCD and its electron donor, i.e., Ncb5or, or Cyb5A and b5R), and NADH.  The 
reaction would be performed to measure MUFA production.  It is challenging to purify 
SCDs, which are integral membrane proteins [137]. Therefore, we directly measured the 
SCD activity in isolated microsomes from WT and Ncb5or
-/- 
mice.  
Specifically, [
14
C] stearoyl-CoA was used as substrate and mixed with hepatic 
microsomes from WT or Ncb5or
-/-
 mice.  We measured the conversion of [
14
C] stearoyl-
CoA to [
14
C] oleoyl-CoA in the presence of NADH to calculate the SCD activity, which 
was then normalized by the SCD protein (or transcript) level to obtain the SCD specific 
activity. 
We observed a near 2-fold increase of SCD activity for Ncb5or
-/- 
microsomes than 
WT under both chow and HF diet (Figure 2.8 A and C). Ncb5or deficiency resulted in 
elevated SCD1 transcript levels under chow (1.9-fold, Table 2.1) and HF diet (9.2-fold, 
Table 2.3), resulting in 20% lower specific activity under chow (Figure 2.8 B) and more 
than 5 fold lower specific activity under HF diet (Figure 2.8 D) compared to WT.  
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We confirmed the correlation between transcript and protein levels by performing 
immunoblot analyses to measure SCD1 protein level in liver of HF-fed mice (Figure 2.8 
E). Around 8-fold higher SCD1 protein level compared to loading control (β-actin) was 
consistent with 9-fold higher transcript levels in Ncb5or
-/- 
liver than WT.  
Our above findings strongly suggest that the “working efficiency” of SCD is 
impaired due to Ncb5or deficiency and that this impairment is dramatically worsened by 
increased metabolic load (HF diet). It is worth noting that the SCD specific activity 
remained the same in Cyb5A
-/-
 and WT microsomes (data not shown). This evidence 
supports our hypothesis that Ncb5or plays an important role in ∆
9
 desaturation pathway 
by facilitating SCD function. Further investigation is needed to determine whether 
Ncb5or functions as an electron donor for SCD or by other mechanisms, such as 
providing iron, which is a cofactor of SCD (see Discussion).  
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Figure 2.8 Stearoyl-CoA desaturase (SCD) activity and levels of SCD1 transcripts 
and SCD immunoreactive protein in hepatic microsomes from Ncb5or
-/-
 and WT 
mice.  SCD activities were measured for WT and Ncb5or
-/-
 liver microsomes of 6-week-
old chow-fed (A) and 4.5-week-old mice after 10-day high-fat diet feeding (C). Absolute 
activities (nmole/min./mg) were divided by SCD1 mRNA (calculated as those in Table 
2.1 and 2.3) to generate “SCD / SCD1 mRNA” as plotted in (B) and (D), respectively. 
Results were obtained from 3 (n=3) chow-fed or 6 (n=6) high-fat animal-pairs and 
expressed as mean ± S.E. (E) Immunoblot analysis showed  > 8-fold more SCD1proteins 
(against β-actin loading control) in liver lysate (n=3 each) of high-fat diet fed Ncb5or
-/-
 
than WT mice. White-bar: WT; Black-bar: Ncb5or
-/-
. *, p<0.05. Dr. Hao Zhu performed 
SCD activity assay. 
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2.4.6 Further impairment of fatty acid ∆
9
 desaturation in mouse livers lacking both 
Ncb5or and Cyb5A.  
 Cyb5A and its cognate reductase Cyb5R3 are known electron donors for SCDs in 
vitro [13; 14; 15], although in vivo evidence is relatively weak. Our own studies suggest 
that Ncb5or plays a role in SCD function, potentially as an electron donor.  
 To dissect the roles of Ncb5or and Cyb5A in vivo, we generated a mouse model 
that lacks both Ncb5or and Cyb5A (double KO, or DKO) in hepatocytes by crossing 
global Ncb5or
-/- 
mice with hepatic Cyb5A
-/- 
mice (HBN) (Figure 2.9). We found DKO 
had significantly lower body weight than WT at age 5 weeks, similar to that of Ncb5or
-/- 
mice, whereas HBN mice had the same body weight as WT (Figure 2.9 A).  
 We next extracted hepatic lipids from these mice and determined fatty acid 
composition of TAG. We detected that hepatic TAG content decreased in both Ncb5or
-/- 
and DKO mice, but not in HBN mice (Figure 2.9 B). Compared to that of WT, DI (C18) 
was lower in liver of Ncb5or
-/- 
(by 1.2 fold) and DKO (by 1.3 fold) mice (Figure 2.9 D). 
Interestingly, DI (C16) appeared to be significantly affected in HBN mice (1.3-fold lower 
than WT, p=0.07), and DKO had the lowest DI (C16) value (1.5-fold lower than WT, 
p=0.05) (Figure 2.9 C). Overall, DKO mice had the most impaired ∆
9
 desaturation in the 
liver, likely due to the overlap of Ncb5or and Cyb5A deficiency. However, this 
impairment in DKO mice is relatively mild in comparison to the greater than 3-fold 
decrease of both DI (C16) and DI (C18) in liver of SCD1
-/-
 mice [138], suggesting the 
lack of total knock down of SCD and the potential existence of other electron donors for 
SCDs.  
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 HBN mice exhibited no major lipid phenotype, as previously reported [132], 
despite a non-significant trend of lower DI (C16) values (Figure 2.9 C). Remarkably, 
livers in Ncb5or
-/- 
mice had lower DI (C18), but not DI (C16). These findings indicated 
that Cyb5A and Ncb5or might have different preference for substrates in vivo, namely, 
Cyb5A for C16:0 and Ncb5or for C18:0. Because C16:0 is the major product of de novo 
fatty acid synthesis, Cyb5A may contribute to desaturation of de novo synthesized SFA, 
whereas Ncb5or may play a more important role in the desaturation of exogenous SFA. 
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Figure 2.9 Body weight and hepatic lipid profile of WT, HBN, Ncb5or
-/-
 and DKO 
mice. Body weight (A) was measured from WT (n=10), HBN (n=7), Ncb5or
-/-
 (n=8) and 
DKO mice (n=7) at 5 weeks. Total TAG content (B), DI, C16 (C) and DI, C18 (D) were 
measured from livers of these 5-week-old mice by GC-MS.  Results are expressed as 
mean ± S.E. *, p<0.05 compared to WT group; #, p<0.05 compared to HBN group;            
$, p<0.05 compared to Ncb5or
-/-
.    
White-bar: WT; Green-bar: HBN; Black-bar: Ncb5or
-/-
; Yellow-bar: DKO. 
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2.5 Discussion 
2.5.1 Ncb5or and fatty acid metabolism 
 Our current study focused on fatty acid metabolism in livers and hepatocytes of 
prediabetic Ncb5or
-/-
 mice. These mice displayed reduced hepatic TAG content and 
impaired ∆
9 
desaturation as early as the weaning age. These observations are consistent 
with our previous findings in older non-diabetic Ncb5or
-/-
 mice that are transplanted with 
WT islets [36].  Together, they suggest that Ncb5or is involved in fatty acid metabolism 
in vivo.  
 To determine the mechanism, we treated primary hepatocytes from prediabetic 
Ncb5or
-/-
 and WT mice with SFA and MUFA. We confirm that Ncb5or deficiency results 
in impaired ∆
9 
desaturation that affects intracellular FFA and TAG pools. Direct 
measurement of SCD activity in liver microsomes confirmed that Ncb5or deficiency 
decreases specific SCD activity.  
 Our working hypothesis is that Ncb5or directly donates electrons to SCD1, 
although we cannot rule out the possibility that Ncb5or might be involved in ferric iron 
reduction to facilitate iron uptake and that iron deficiency in Ncb5or
-/-
 mouse  livers 
(Chapter 4) indirectly affects activity of an iron-dependent SCD enzyme. To further 
examine the role of Ncb5or in SCD reaction, in vitro reconstitution of SCD will be 
attempted with recombinant Ncb5or and pure SCD proteins that are generated from a 
cell-free translation system [139].  
 Ncb5or deficiency also leads to over-accumulation of intracellular FFA. 
Cytotoxicity of these FFA, especially SFA, will be examined in the next chapter.        
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2.5.2 Animal vs. primary cell culture model 
 Our studies employed both animal (in vivo) and primary hepatocytes (ex vivo) 
models. Although the same overall conclusion is reached, there are minor differences 
between the two systems.  
 Compared to WT, prediabetic Ncb5or
-/-
 mice had lower hepatic TAG content, 
despite intact TAG synthesis in hepatocytes. A high fat diet rich in SFA and MUFA 
induces hepatic TAG synthesis in Ncb5or
-/-
 mice to restore the TAG content, which is 
consistent with that in Ncb5or
-/-
 hepatocytes under co-incubation with SFA and MUFA. 
However, no altered expression of lipid synthesis enzymes was observed in hepatocytes, 
in contrast to highly induced expression of these genes in liver of HF fed mice.  
 Intracellular FFA levels remained higher in liver of Ncb5or
-/-
 mice on HF than 
WT, but similar in Ncb5or
-/-
 hepatocytes under co-incubation of SFA and MUFA. The 
following four factors may be responsible for this difference. 1) Nature of lipid species in 
which the fatty acid equivalents are provided. In the animal model, dietary fatty acids are 
esterified in TAG form and the amount of FFA is low. In contrast, cells are treated with 
BSA complexed fatty acids. 2) Treatment duration. Mice were fed high fat diet for 10 
days, but hepatocytes were incubated for only 8 hours to observe the acute response. It is 
possible that co-incubation with SFA and MUFA is beneficial only in the initial phase but 
causes other problems such as elevated FFA levels at later times. 3) Amount of fatty 
acids. We treated hepatocytes with 0.25 mM C16:0 and 0.25 mM C18:1.  These doses are 
higher than physiological concentration of fatty acids in circulation. 4) Potential 
contribution from other tissues in animals. Adipose tissues and skeletal muscles play 
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important roles in regulating hepatic fatty acid metabolism [48]. All these factors should 
be considered when we compare studies in animals and those in primary cell cultures.      
2.5.3 Ncb5or and Cyb5A 
 Cyb5A has been long considered a major electron donor for SCD [13; 14; 15]. 
Our findings of Ncb5or suggest that other electron donors, such as Ncb5or, may play an 
important role. Our preliminary initiated studies on the functional relationship between 
Ncb5or and Cyb5A in vivo. By using congenic mouse lines lacking Ncb5or, Cyb5A,  or 
both, we discovered that Ncb5or affects more body weight, hepatic TAG content and 
desaturation of C18 fatty acids than Cyb5A, which appears more responsible for 
converting C16:0 to C16:1. Among all three lines, mice lacking both Ncb5or and Cyb5A 
display the biggest defects in fatty acid metabolism, but it is much less severe compared 
to SCD1 null mice.   
 One plausible explanation is that both Ncb5or and Cyb5A function as electron 
donors for SCDs. The phenotype of DKO mice suggests that SCD may use some other 
electron donors besides Ncb5or and Cyb5A. One such candidate is outer mitochondrial 
cytochrome b5 (Cyb5B). Microsomes are the major subcellular locus for lipid synthesis, 
including fatty acid desaturase, therefore, Cyb5B in mitochondria is likely not a natural 
source of electrons for SCD in WT cells but provides an alternative source when both 
Ncb5or and Cyb5A are deficient.  
 Our current study relies on three congenic mutant lines, all of which are in the 
C57BL/6 genetic background.  There are some limitations, however, of these mice. 
Ncb5or 
-/-
 mouse is a global knockout model, whereas HBN mice only have hepatic 
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deficiency of Cyb5A. Although liver is the focus of our current studies, other tissues in 
Ncb5or
-/-
 mice might affect hepatic lipid metabolism. Therefore, further experimentation 
using hepatocytes-specific knockout mouse model is important to dissect the role of 
Ncb5or and Cyb5A in hepatic fatty acid metabolism. Future experiments may include 
treating hepatocytes of these mice with isotope-labeled substrates, such as exogenous 
SFA or acetate (precursor for de novo fatty acid synthesis), to determine whether they are 
preferred substrate for Ncb5or and Cyb5A in fatty acid metabolism.  
2.5.4 Conclusion 
In this chapter, we systematically studied the role of Ncb5or in fatty acid 
metabolism and validated the role of Ncb5or in ∆
9
 fatty acid desaturation pathway as a 
potential electron donor with in animal and cell models. We characterized the loss of 
TAG content as the major defect in Ncb5or
-/-
 hepatocytes and were able to rescue it by 
10-dayhigh fat feeding. We also revealed the abnormal response to SFA in Ncb5or
-/-
 
hepatocytes. Our preliminary data provided clues about the different roles of Ncb5or and 
Cyb5A in fatty acid desaturation. All these findings allow us to have a better 
understanding of lipid metabolism in animals. This knowledge is essential for our future 
endeavor of developing Ncb5or and its pathway as a potential therapeutic target. 
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Chapter 3 
 
 
 
 
Ncb5or and oxidative stress 
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3.1 Abstract    
Our recent studies show that Ncb5or is involved in ∆
9
 fatty acid desaturation and that 
Ncb5or deficiency leads to accumulation of SFA in intracellular free fatty acid and 
triacylglycerol (TAG) pools. Here we investigate the underlying mechanism of cytotoxicity 
of SFA in Ncb5or
-/-
 hepatocytes. We found that accumulation of SFA in Ncb5or
-/-
 
hepatocytes induced mitochondrial biogenesis and fatty acid catabolism through β-oxidation.  
These responses resulted in oxidative stress, but not ER stress, and cell death, which can be 
alleviated by co-incubation with palmitate and oleate via channeling free SFA into TAG. 
We also observed higher mitochondrial content and oxidative stress in Ncb5or
-/-
 liver, as 
well as elevated whole-body oxygen consumption in prediabetic Ncb5or
-/-
 mice compared to 
WT. In summary, our study revealed an important role of Ncb5or in protecting cells against 
SFA-induced oxidative stress.  
 
3.2 Introduction  
Over-accumulation of intracellular fatty acids  impairs cell function and causes 
cell death, a process often called “lipotoxicity” [79]. Free SFAs, such as palmitate, are the 
most toxic fatty acid species. Previous studies show that Ncb5or
-/-
 hepatocytes are more 
sensitive to cytotoxic effects of SFAs than WT [35; 36]. We have recently shown that 
Ncb5or
-/-
 hepatocytes over-accumulate free SFAs, which is worsened under SFA 
treatment but attenuated by co-incubation with SFA and MUFA.  
Oxidative stress [83; 84] and ER stress [35; 86; 87] are two major mechanisms 
that have been implicated in SFA-induced cytotoxicity. In this chapter, we investigated 
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the functional relationship between SFA accumulation and cell death in Ncb5or
-/-
 
hepatocytes and examined the role of oxidative and ER stress in SFA-induced 
lipotoxicity. 
The major source of oxidative stress is reactive oxygen species (ROS), which 
include superoxide (O2
-
), hydrogen peroxide (H2O2) and hydroxyl radical 
(HO
.
).Glutathione is the most abundant antioxidant inside animal cells, and reduced 
glutathione (GSH) can convert H2O2 to H2O.  Oxidative stress also induces the 
expression of stress response genes, such as GCLC, HMOX1, and MT1, as described in 
Chapter 1.    
Our recent studies suggested that ER stress is involved in SFA induced 
cytotoxicity in -cells [34] and hepatocytes of prediabetic Ncb5or
-/-
 mice [35]. In this 
study, we also investigated the expression of ER stress response genes as those 
mentioned in Chapter 1. In this chapter, we employed Ncb5or
-/-
 hepatocytes, liver and 
whole animals to examine the role of increased fatty acid catabolism, oxidative and ER 
stress in SFA-induced cytotoxicity.  
 
3.3 Methods 
3.3.1 Mouse models  
 Ncb5or
-/-
 mice in C57BL/6 strain were generated as described in section 2.3.1. All 
experiments employed pre-diabetic male mice. The glucose levels were measured for 
these mice using OneTouch Ultra glucometer (LifeScan, Milpitas, CA) to make sure that 
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the mice were non-diabetic. The experimental protocol was approved by the Institutional 
Animal Care and Use Committee at the University of Kansas Medical Center.  Standard 
rodent chow (Purina 5015 from LabDiet, St. Paul, MN) was used for mice in C57BL/6. 
3.3.2 Hepatocytes isolation and fatty acid treatment. 
 Same as that described in section 2.3.2  
3.3.3 Cell viability assay 
  Cell viability was determined by intracellular ATP content using CellTiter-Glo 
(R) Luminescent Cell Viability Assay (Promega) and by live-cell protease activity using 
MultiTox-Fluro Multiplex Cytotoxicity Assay (Promega). The latter assay uses a 
fluorogenic and cell-permeant peptide substrate (glycyl-phenylalanyl-amino-
fluorocoumarin; GF-AFC), which generates fluorescent signal after being cleaved by 
protease in live cells.  Opaque-walled 96 wells (Corning) were used for assays with 
20,000 cells in each well. Triplicates were measured for each condition.  
3.3.4 RNA extraction and quantitative PCR 
 Same as that described in section 2.3.3 
3.3.5 Lipid profiling and total content assay 
 Same as that described in section 2.3.5   
3.3.6 Fatty acid oxidation (FAO) assay 
The rate of mitochondrial FAO was calculated by measuring the oxidized product of 
[n9,10-
3
H] palmitic acid (Perkin Elmer Life Science, Boston, MA) as described [140].  
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Briefly, 1 x 10
5
 hepatocytes were seeded in wells of a 24-well plate, incubated overnight in 
medium with 10% FBS, and then incubated at 37°C with palmitic acid (BSA-PA complex) 
(0.125 mM unlabeled plus 0.08 Ci [n9,10-
3
H]-C16:0) in the presence of carnitine (1 mM) 
for 2 hours. The amount of substrate taken up by cells within 2 hours represented less than 
25% of the total amount in the medium. The H[
3
H]O product was collected and its [
3
H] 
content was determined by liquid scintillation spectrometry (LS6500 Scintillation Counter, 
Beckman-Coulter, Brea, CA) to calculate the initial reaction rate (mmol/hr/mg protein). The 
protein contents of cells were measured with a BCA protein analysis kit (Pierce) to 
normalize the reaction rate.  
3.3.7 Extracellular flux analysis 
Extracellular flux analysis was performed on a XF24 analyzer (Seahorse Bioscience, 
Billerica, MA) as previously described [141].  Briefly, 3 x 10
4
 hepatocytes were seeded into 
24-well plates and cultured overnight in complete medium with 10% FBS (see section 2.3.2).  
Cells were washed with DMEM without buffer carbonate (0.8 mM MgSO4, 1.8 mM CaCl2, 
143 mM NaCl, 5.4 mM KCl, 0.91 mM NaH2PO4, 15 mg/ml Phenol Red, 5.5 mM glucose, 
and 2 mM GlutaMAX from Invitrogen) once and incubated in the same medium at 37°C for 
1 hour without CO2 preincubation. Cells were then loaded into the XF24 analyzer to 
measure oxygen consumption rate (OCR) in short and repeated intervals as cells alone 
(baseline) and after injection with buffer or palmitate or oleate (0.125 mM) in the presence 
of carnitine (1 mM). The mitochondrial integrity was also measured by sequential addition 
of buffer, oligomycin (inhibitor of mitochondrial ATP synthesis, 10 M), FCCP 
(carbonylcyanide-p-trifluoromethoxyphenylhydrazone, mitochondrial uncoupler, 6 M), and 
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rotenone / antimycin (inhibitor for complex I / III, 4/8 M, respectively) in separate plates. 
OCR values under each condition were normalized to total protein content.     
3.3.8 Measurement of glutathione 
Reduced and oxidized glutathione in liver tissue or hepatocytes was measured as 
described [142]. The principle of this assay is that 5,5'-dithiobis-2-nitrobenzoic acid 
(DTNB) can react with GSH to form 5-thio-2-nitrobenzoate (TNB), which can be 
detected spectrophotometrically at 412 nm. For GSSG measurement, N-ethylmaleimide 
(NEM) was used to react with the free thiol in GSH, thus preventing it from reacting with 
DNTB.  GSSG is then reduced back to GSH by glutathione reductase (GR) (Figure 3.1). 
To avoid interfere with GR reaction, excess NEM were first removed by binding to a C18 
SepPak hydrophobic column. 
The exact procedure is as follows. Hepatocytes were washed 3 times with ice-old 
PBS and were then scraped off from the plate in 500 µl ice-cold 3% SSA (3% sulfosalicylic 
acid with 0.1 mM EDTA) per well to precipitate proteins. Two wells (600,000 cells) of the 
same treatment were combined as one sample.  For liver, frozen tissues (~50 mg) were 
homogenized in 3% SSA to remove proteins. After vortexing to lyze the cells and 
precipitating proteins, samples were centrifuged at 16,000g for 5 minutes (4°C) to pellet 
down proteins.  
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Figure 3.1 Principle of GSSG/GSH assay.  DTNB reacts with GSH to form TNB, 
which can be detected spectrophotometrically at 412 nm.  
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Each supernatant (total ~ 1 ml) was transferred into two new 1.5-ml tubes, one to be 
assayed for total glutathione, i.e., GSH + GSSG (500 l), and the other for GSSG only (500 
l, to be processed as below before the assay). Each protein pellet was dissolved in 10% 
SDS at room temperature for 1-4 days and measured for protein content with BCA kit 
(Pierce).The supernatant for GSSG assay was mixed well with 1 ml NEM solution 
containing 1.25 mg NEM (Sigma) in KPP buffer (100 mM potassium phosphate pH 6.5, 
17.5 mM EDTA). Excess NEM and NEM-GSH conjugates were removed by SepPak 
cartridge (Waters), which was pre-washed with methanol and excess water. The flow-
through was collected for assay.  
The DNTB reaction system contained two solutions: Solution #1 (1.2 mM DTNB in 
600 mM potassium phosphate pH 7.2, 30 mM EDTA, and 0.08% BSA), and Solution #2 
(100 mM imidazole pH 7.2, 2 mM EDTA, and 0.04% BSA). All solutions and KPP buffers 
were warmed to room temperature before the assay. Then 0.5 mg NADPH (Sigma) and 6 
µl/ml glutathione reductase (GR) (Sigma) were added into Solution #2. The GSH+GSSG 
(total) samples were diluted by 100-fold in KPP buffer, but no dilution was needed for 
GSSG samples. For each sample or standard, 500 l sample was added into a plastic cuvette, 
then mixed with 150 l Solution #1 and 150 l Solution #2. After 10-minute incubation at 
room temperature, the absorbance at 412 nm was determined using a UV-Vis 
spectrophotometer (such as Cary 50, VARIAN). Concentrations of total (GSH+GSSG) and 
GSSG were calculated using the standard curve. All chemicals were obtained from Sigma 
unless otherwise indicated.  
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3.3.9 Measurement of cellular ROS  
Cellular hydrogen peroxide and nuclear DNA levels were determined by staining 
with 2',7'-dichlorofluorescein diacetate (DCFH-DA, Sigma) and Hoechst 33342 (Molecular 
Probes, Eugene, OR), respectively. DCFH-DA is commonly used to measure the 
intracellular level of ROS. After diffusing into the cell, DCFH-DA will be deacetylated to 
nonfluorescent 2’,7’-dichlorofluorescin (DCFH), which will then be rapidly oxidized to 
highly fluorescent 2’,7’-dichlorofluorescein (DCF) by ROS. Therefore, the DCF-associated 
fluorescence can represent intracellular ROS level and be monitored and measured by ocular 
fluorophotometry. 
The exact procedure is described as follows. One well of hepatocytes (300,000) from 
each group was used.  All procedures were performed in dim light or in the dark to avoid 
degradation of the DCF dye. A stock solution of 2 mM DCFH-DA was made by dissolving 
the powder in DMSO. The staining medium was made of 2 M DCFH-DA in Williams’ 
medium E containing penicillin /streptomycin and glutamine, and incubated in a 37°C water 
bath for one hour immediately before use. Hepatocytes were washed with PBS once before 
incubation in staining medium (1 ml per well) for 20 minutes at 37°C. Afterwards, medium 
was removed and cells were washed with PBS once before being incubated in Williams’ 
medium E (1 ml per well) for 20 minutes at 37°C. A florescence microscope (ZEISS, 
observer A1) was used to observe and record DCF signals with a GFP filter and cell 
morphology with DIC filter.  
For fluorescence reading, cells were washed with PBS once and then incubated in 
37°C with 2 µM DCFH-DA and 0.1 µg/ml Hoechst in HBSS (with Ca
2+
 and Mg
2+
 but 
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without phenol red) for 20 min in the dark. Cells were collected by trypsinization and 
resuspended in PBS plus 20 mM glucose at a density of 1×10
6
 cells/ml.  Fluorescence 
measurements were performed in clear 96-well plates at excitation/emission wavelengths of 
480/533 nm for DCF signals or at 355/460 nm for Hoechst signals on a SpectraMax M5 
microplate reader (Molecular Devices, Sunnyvale, CA).  Cellular ROS level was normalized 
to nuclear DNA content, which is represented by the DCF:Hoechst ratio.  
3.3.10 Ceramide analyses  
Upon the completion of fatty acid treatment (0.5 mM C16:0 or C18:1), 
hepatocytes from each 6-cm plate (900,000 cells) were rinsed with isotonic LiCl before 
lipid extraction by the method of Bligh and Dyer [143].  Ceramide (CM) species were 
measured to C8:0-CM internal standard by negative ion ESI (electrospray ionization)/MS 
as previously described [144]  and normalized to sample protein content. 
3.3.11 Indirect calorimetry 
 Indirect calorimetry was conducted in a 4-chamber OxyMax System from 
Columbus Instruments (Columbus, OH). The O2 and CO2 gas fractions were monitored at 
both the inlet and output ports with a flow rate of 0.4 liter/minute. These measurements 
were used to compute VO2 and VCO2 values (10 minutes per data point) in units of 
ml/kg/hour. Respiratory exchange rate (RER) was calculated as “VCO2/VO2” and used to 
predict the likely fuel source, i.e., RER = 1.0 (carbohydrates), 0.7 (fat), or 0.85 (proteins 
or a combination of carbohydrates and fats). 
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3.3.12 Electron Microscopy 
 Transmission electron microscopy was performed in the Electron Microscopy 
core facility at KUMC. Fresh liver pieces (~1 mm
3
 in size) were fixed in 2.5% 
glutaraldehyde in 0.1 M NaCacodylate buffer overnight and post fixed with 2% osmium 
tetroxide for one hour before being processed and embedded in EPON. Thin sections 
were placed on copper grids and stained with 1% uranyl acetate. Micrographs were 
obtained with a JEOL (Tokyo, Japan) 100 CXII transmission electron microscope that 
was operated at 80 kV. The NIH Image J software was used for counting mitochondrial 
and cytoplasmic area. 
3.3.13 Mitochondrial DNA content measurement 
Quantitative PCR was performed to determine the relative copy numbers of 
mitochondrial DNA (mtDNA) and nuclear DNA (nDNA) in livers from 5-week-old WT 
and Ncb5or-/- mice. Each reaction (10 µL) contained genomic DNA (100 ng) and 
forward and reverse primers (0.6 µM each). Hexokinase 2 (intron 9) and 16S rRNA were 
used as nDNA- and mtDNA-specific targets, respectively, as described by others [145]. A 
standard dilution series was used to confirm the efficiency of exponential amplification 
for each primer pair. Mitochondrial to nuclear DNA ratio in each sample was calculated 
by dividing the value of 16S by that of hexokinase 2. 
3.3.14 TNFα level measurement 
 Duoset Mouse TNFα ELISA kit from R&D systems (Minneapolis, MN) was used 
to detect the TNFα level in serum according to the manufactory’s instruction. Fifty µl of 
serum was used in each assay. 
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3.3.15 Data analysis 
 One-way analysis of variance (ANOVA) was used to detect the significant 
difference within and between groups. A value of p<0.05 was considered statistically 
significant. Data are presented as the mean ± standard error of the mean (S.E.). 
 
3.4 Results 
3.4.1 Increased cell death in Ncb5or
-/-
 hepatocytes under SFA challenge  
 In our previous study (Chapter 2), we observed higher intracellular levels of free 
SFAs in Ncb5or
-/-
 hepatocytes than WT under both basal condition and C16:0 treatment 
(Figure 2.6).   Here we examined SFA-induced cytotoxicity in Ncb5or
-/-
 hepatocytes.  
Previous studies showed Ncb5or
-/-
 hepatocytes were more sensitive to SFA 
treatment [35; 36]. In these studies, hepatocytes were potentially starved at the end of 
treatment, because they were cultured in medium without FBS, which resulted in low 
level of fatty acids left in medium after a 12-hour treatment.  The SFA-induced 
cytotoxicity in these Ncb5or
-/-
 hepatocytes might be caused by nutrient starving instead of 
SFA itself. To avoid these complications, we used a nutrient-rich medium containing 
10% FBS for preincubation and shortened the duration of fatty acid treatment from 12 to 
8 hours. Under these conditions, more than 20% of fatty acids still remained in the 
medium at the end of treatment.  
 Under these experimental conditions, we observed that treatment of 0.25 mM 
palmitate (C16:0) resulted in cell death in 10% of Ncb5or
-/-
 hepatocytes, and the rate 
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increased to 40% with 0.5 mM C16:0, in contrast to a level below detection and 10% in 
WT hepatocytes that are treated with 0.25 and 0.5 mM C16:0, respectively (Figure 3.2 
A). C18:1 did not affect cell viability in WT or Ncb5or
-/-
 hepatocytes, and co-incubation 
with C16:0 and C18:1 completely rescued the SFA cytotoxicity in Ncb5or
-/-
 hepatocytes 
(Figure 3.2 A). The above cell viability was determined by measuring intracellular ATP 
levels. Since Ncb5or
-/-
 hepatocytes had abnormal metabolism, which may affect the ATP 
level, we used another assay that measured live-cell protease activity.  Similar results 
were obtained with the latter method (Figure 3.2 B), further confirming increased SFA 
cytotoxicity in Ncb5or
-/-
 hepatocytes.    
 To find out whether lipotoxicity is specific to SFA in Ncb5or
-/-
 hepatocytes, we 
treated Ncb5or
-/-
 and WT hepatocytes with various concentrations of glucose, which is 
another major source of energy, as well as H2O2. We found that Ncb5or
-/-
 and WT 
hepatocytes had similar cell viability under all concentrations of glucose ranging 11 – 
500 mM (Figure 3.3 A). Secondly, we treated Ncb5or
-/-
 and WT hepatocytes with various 
concentrations of H2O2 for 2 hours. We found that Ncb5or
-/-
 hepatocytes displayed higher 
viability than WT when treated with 0.25 mM (Figure 3.3 B), which likely reflects higher 
expression levels of antioxidant genes in Ncb5or
-/-
 hepatocytes than WT (discussed 
below).  
Cytotoxicity in Ncb5or
-/-
 hepatocytes appeared to be specifically caused by long-
chain SFA, such as C16:0.  MUFA not only caused no cytotoxicity but also rescued SFA-
induced cytotoxicity (Figure 3.2).  This is likely achieved by channeling free SFA to 
TAG, which were shown in our earlier studies (Figure 2.4 and 2.6).  
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Figure 3.2 Effects of incubation with palmitate and oleate on cell viability in  
Ncb5or
-/-
 and WT hepatocytes. Hepatocytes were isolated as above and treated with 
BSA carrier (vehicle control, -) or palmitate (C16:0) or oleate (C18:1) for 8 hours. (A) 
Cell viability was assessed by measuring cellular ATP content. The results were obtained 
from 7 animal-pairs (n=7). (B) Cell viability was assessed by measuring live-cell protease 
activity from 3 animal-pairs (n=3). All results were expressed as mean ± S.E. *, p<0.05. 
White-bar: WT; Black-bar: Ncb5or
-/-
. 
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Figure 3.3 Effects of incubation with glucose or H2O2 on cell viability in Ncb5or
-/-
 
and WT hepatocytes. (A) Hepatocytes were treated with different concentrations of 
glucose for 8 hours. (B) Hepatocytes were treated with different concentrations of H2O2 
for 2 hours. All hepatocytes were isolated as above. Cell viability was assessed by 
measuring cellular ATP content in both cases. All results were obtained from 6-12 wells 
of cells from 2-4 animal-pairs and expressed as mean ± S.E. *, p<0.05. White-bar: WT; 
Black-bar: Ncb5or
-/-
.   Ncb5or
-/-
 cells displayed a higher viability (p=0.06, n=3) than WT 
after 0.25 mM H2O2 treatment. 
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3.4.2 Increased oxidative stress in Ncb5or
-/-
 hepatocytes under SFA treatment 
 We next investigated the mechanism of SFA induced cell death. Previous studies 
by others suggest that SFAs induce cell death through the following pathways: ceramide 
signaling [81], phospholipid remodeling [82], oxidative stress [83; 84] and ER stress [35; 
86; 87]. Here we examined these pathways one by one.  
We measured levels and profiles of intracellular ceramide in Ncb5or
-/-
 and WT 
hepatocytes after the treatment with 0.5 mM C16:0 or C18:1 or vehicle (BSA) control. 
Surprisingly, we observed no difference between the two genotypes under all three 
conditions (Figure 3.4), suggesting that SFA cytotoxicity in Ncb5or
-/-
 hepatocytes is 
independent of ceramide [81].  
Next, we measured the fatty acid composition of phospholipids of these hepatocytes. 
We found that, under C16:0 incubation, Ncb5or
-/-
 hepatocytes appeared to accumulate less 
phospholipid (PL) content (p=0.07) and to have lower values of DI (C16) than WT (Figure 
3.5). These observations suggested a phospholipid remodeling in Ncb5or
-/-
 hepatocytes, 
which could lead to the impairment of ER and mitochondrial function (to be tested below).  
We evaluated oxidative stress and ER stress response in Ncb5or
-/-
 and WT 
hepatocytes under SFA treatment. We found that, under basal condition and C16:0 
incubation, Ncb5or
-/-
 hepatocytes expressed higher transcript levels of mitochondrial 
biogenesis gene (PGC1α) and oxidative stress responses genes (HMOX1, GCLC, MT1 and 
MT2) than WT cells, and the fold of induction increased with increasing concentrations of 
C16:0.  These effects were prevented by co-incubation of C16:0 with C18:1 (Figure 3.6).  
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To examine whether transcript levels of oxidative stress response genes correlated 
with intracellular ROS level, we subjected Ncb5or
-/-
 and WT hepatocytes to DCF staining 
for direct measurement of ROS. We detected stronger signals of DCF by both assessing 
fluorescence signals (Figure 3.7 A) and confocal microscopy (Figure 3.8) in Ncb5or
-/-
 
hepatocytes than WT under the C16:0 treatment.  
We next measured intracellular levels of oxidized and reduced glutathione in these 
cells.  We observed higher GSSGH:GSH ratios in SFA-treated Ncb5or
-/-
 hepatocytes than 
WT cells (Figure 3.7B), whereas no significant difference was found for total glutathione 
level (Figure 3.7C). Co-incubation with C18:1 decreased GSSG/GSH ratios and intracellular 
levels of ROS in Ncb5or
-/-
 hepatocytes. To avoid complications from dead cells, we used 
0.25 mM C16:0 in these two experiments, under which more than 85% of Ncb5or
-/-
 
hepatocytes survived after 8 hours. Because DCF oxidation reflects the level of ROS and 
because GSSG is generated from GSH through the reduction of ROS, we concluded that 
SFA induced more ROS in Ncb5or
-/-
 hepatocytes. This observation is concordant to that of 
SFA induced cell death, which strongly suggested that ROS played an important role in SFA 
cytotoxicity in Ncb5or
-/-
 hepatocytes. Ncb5or
-/-
 hepatocytes had slightly better tolerance to 
exogenous ROS compared to WT (Figure 3.3B), suggesting that increased levels of ROS, 
rather than loss of antioxidant capacity, is likely responsible for cell death.  
We also examined the potential involvement of ER stress by measuring transcript 
levels of ER stress response genes. In contrast to the previous finding [35], no obvious ER 
stress response was observed in Ncb5or
-/-
 hepatocytes under SFA treatment (Figure 3.9), 
despite a similar trend of ER stress. Our findings suggest that ER stress is not a major 
contributor to cell death compared to oxidative stress.      
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Figure 3.4 Ceramide profile of Ncb5or-/- and WT hepatocytes after fatty acid 
treatments.  Hepatocytes were isolated and treated with palmitate or oleate (0.5 mM 
each) or BSA carrier alone (control) as above. Total ceramide profiles were measured 
relative to a C8:0-CM internal standard by negative-ion ESI/MS and normalized to 
sample protein content. Results were obtained from 3 animal-pairs (n=3) and one 
representative set is shown with major ceramide species as labeled.  (A) WT with BSA 
carrier; (B) WT with 0.5 mM palmitate; (C) WT with 0.5 mM oleate; (D) Ncb5or
-/-
 with 
BSA; (E) Ncb5or
-/-
 with 0.5 mM palmitate; (F) Ncb5or
-/-
 with 0.5 mM oleate. Dr. Fong-
Fu Hsu in Washington University in St. Louis performed the ceramide analyses. 
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Figure 3.5 Effects of incubation with palmitate and oleate on Ncb5or
-/- 
and WT
 
hepatocyte in PL pools.  Hepatocytes were isolated and treated with palmitate or oleate 
or BSA carrier alone. Intracellular phospholipids were prepared and analyzed for 
determination of lipid profiles by GC/MS. The total content, desaturation index of 
C16:1/C16:0 and C18:1/C18:0 were determined. Results were obtained from 3 animal-
pairs (n=3) for PL profiling and expressed as mean ± S.E. White-bar: WT; Black-bar: 
Ncb5or
-/-
. 
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Figure 3.6 Effects of incubation with palmitate and oleate on expression of genes 
involved in mitochondrial biogenesis and oxidative stress responses in Ncb5or
-/-
 and 
WT hepatocytes. Hepatocytes were isolated and treated with palmitate or oleate or BSA 
carrier alone (see above). Total RNAs were collected and used for quantitative RT-PCR. 
Results were obtained from 4-6 animal-pairs (n=4-6) and expressed as mean ± S.E. *, 
p<0.05. White-bar: WT; Black-bar: Ncb5or
-/-
. 
87 
 
 
Figure 3.7 Effects of incubation with palmitate and oleate on oxidative stress in 
Ncb5or
-/-
 and WT hepatocytes. Hepatocytes were isolated as above and treated with 
BSA carrier (vehicle control, -) or palmitate (C16:0) or oleate (C18:1) for 8 hours. (A) 
Intracellular H2O2 content was assessed with DCFH-DA, and relative intensity of 
fluorescence signals against nuclear DNA content (Hoechst staining signal) was used in 
comparison. Intracellular glutathione levels were measured and are displayed as (B) 
GSSG/GSH ratio and (C) GSH+GSSG (total glutathione content).  All results were 
obtained from 4-6 animal-pairs (n=4-6) and expressed as mean ± S.E. *, p<0.05. White-
bar: WT; Black-bar: Ncb5or
-/-
. 
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Figure 3.8 Images of DCF-stained hepatocytes after fatty acids treatment. 
Hepatocytes were isolated and treated with palmitate (C16:0, 0.25 mM) or a combination 
of palmitate and oleate (C16:0+C18:1, 0.25 mM each) or BSA carrier alone (- control) 
for 8 hours as above.  For confocal microscopy, cells were seeded in 12-well plates and 
incubated in the dark with 2 µM DCFH-DA at 37°C for 20 minutes in HBSS.  Cells were 
then washed with HBSS once and subjected to Olympus Fluoview 300 confocal 
microscopy to record fluorescence (488 nm excitation / 530 nm emission) and light 
microscopy images with the same settings. 
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Figure 3.9 Effects of incubation with palmitate and oleate on expression of genes 
involved in ER oxidative stress responses in Ncb5or
-/-
 and WT hepatocytes. 
Hepatocytes were isolated and treated with palmitate or oleate or BSA carrier alone (see 
above). Total RNAs were collected and used for quantitative RT-PCR. Results were 
obtained from 4-6 animal-pairs (n=4-6) and expressed as mean ± S.E. White-bar: WT; 
Black-bar: Ncb5or
-/-
. 
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3.4.3 Higher rates of hepatic fatty acid oxidation and cellular respiration in Ncb5or
-/-
 
hepatocytes than WT 
Our findings suggest that oxidative stress is the major contributor to cell death in 
Ncb5or
-/-
 hepatocytes. Also, phospholipid remodeling induced mitochondrial 
dysfunction, which might also play a role. Here, we further examine the cause of SFA 
induced oxidative stress in Ncb5or
-/-
 hepatocytes.  
There are four major cellular sources for ROS production as described in Chapter 
1. Elevated level of NADPH oxidase (NOX) is a possibility, but it is excluded by the fact 
that no difference in hepatic transcript levels of NOX3 and NOX4 was found between 
Ncb5or
-/-
 and WT mice (data not shown).  
The second potential source is peroxisomes, which can generate H2O2 through β-
oxidation of long chain fatty acids when mitochondrial β-oxidation is overwhelmed [102]. 
We measured the transcript levels of ACOX, the peroxisome specific enzyme catalyzing 
the first oxidation step, in the hepatocytes that were treated with SFA or MUFA. We 
observed no significant difference between the two genotypes under all treatments, even 
with 0.5 mM C16:0 (data not shown). We concluded that SFA induced ROS generation is 
independent of peroxisome.  
ER is estimated to contribute as much as 25% of total cellular ROS production 
[129]. We detected mild ER stress in Ncb5or
-/-
 hepatocytes (Figure 3.9) but not under the 
same condition that oxidative stress was detected, i.e., 0.25 mM C16:0 treatment (Figures 
3.6 and 3.7). These findings suggest that Ncb5or
-/-
 hepatocytes are more sensitive to 
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oxidative stress than ER stress and that oxidative stress is a more prominent event in 
these cells.  
Here we examined mitochondrial source in depth, because a high flux of ETC can 
induce electron leakage to generate ROS. We showed earlier (Figure 2.6) that Ncb5or
-/-
 
hepatocytes accumulate more palmitate, which is a common substrate for β-oxidation.   
We determined the rates of fatty acid oxidation (FAO) in Ncb5or
-/-
 and WT 
hepatocytes using isotope labeled substrate, i.e. [n9,10-
3
H] palmitate and measuring its 
end product through FAO ([
3
H]HO). After 2 hours of incubation, we observed a 30% 
increase of FAO rates in Ncb5or
-/-
 hepatocytes than WT (Figure 3.10 A). This increase in 
FAO mostly occurred in mitochondria, since we observed no difference between the two 
genotypes in expression of genes involved in peroxisomal FAO (see above).  
Higher FAO rates indicate that cells produce at higher levels not only FADH2 and 
NADH, but also acetyl-CoA, all of which can increase the flux of ETC either directly or 
indirectly through the TCA cycle. To determine whether this is the case in Ncb5or
-/-
 
hepatocytes, we measured total cellular oxygen consumption rate (OCR) of these 
hepatocytes under basal condition and upon the addition of SFA and MUFA. Excess 
carnitine was added to facilitate mitochondrial entry in this experiment as well as in FAO 
assay. The ETC in mitochondria consumes oxygen to produce ATP, thus the baseline 
OCR represents the rate of ETC. We observed that Ncb5or
-/-
 hepatocytes had higher OCR 
values than WT under the basal condition and that the addition of either C16:0 or C18:1 
increased OCR in both Ncb5or
-/-
 and WT hepatocytes (Figure 3.10 B). It is important to 
note that C16:0 induced a significantly bigger increase in OCR in Ncb5or
-/-
 hepatocytes 
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than WT, whereas the difference between the two genotypes was not significant with the 
addition of C18:1 (Figure 3.10 C). Compared to WT, higher basal OCR values in  
Ncb5or
-/-
 hepatocytes suggested a more active flux of ETC in these cells.  The greater 
induction of OCR by C16:0, but not C18:1, in Ncb5or
-/-
 hepatocytes reflects their higher 
capacity to catabolize SFA, which are more abundant in these cells than in WT.  
We next investigated whether significantly higher ROS levels in Ncb5or
-/-
 
hepatocytes than WT (Figure 3.7) could be due to mitochondrial dysfunction, which has 
been shown to exaggerate the ROS production. By using an extracellular flux analyzer, 
we measured mitochondrial function in response to the following compounds that were 
added in sequence to primary hepatocytes. The first compound was oligomycin that 
inhibits mitochondrial ATP synthesis and its associated oxygen consumption.  The trace 
of OCR correlates to cellular respiration independent of ATP synthesis, which is caused 
by H
+
 leakage from ETC. The second compound was carbonyl cyanide-p-
trifluoromethoxy phenylhydrazone (FCCP). FCCP is a potent uncoupler of mitochondrial 
proton gradient and makes cells to bypass the ATP synthesis and to dissipate the proton 
gradient for heat. Upon the addition of FCCP, OCR increases to the maximum level, 
which represents the maximum respiratory capacity. The third compound was a mixture 
of rotenone and antimycin, which inhibits complex I and III, respectively. In this case, the 
flow of electrons in mitochondrial ETC will completely cease and all mitochondrial 
respiration will stop.  
As shown in Figure 3.11, Ncb5or
-/-
 and WT hepatocytes displayed a similar 
response to all the above compounds. This indicates that there is no difference between 
the two genotypes in H
+
 leakage and in maximum respiratory capacity of mitochondria in 
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hepatocytes. In other words, the mitochondria in Ncb5or
-/-
 hepatocytes remained intact 
and functional. Therefore, higher rates of FAO and OCR in Ncb5or
-/-
 hepatocytes could 
simply reflect the increases in mitochondrial capacity in association with the over-
abundance of substrates (SFAs) and higher mitochondrial density (see below) in these 
cells.  
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Figure 3.10 Mitochondrial fatty acid oxidation in Ncb5or
-/-
 and WT hepatocytes (A) 
The rate of mitochondrial fatty acid oxidation (FAO) rate was determined by incubating 
cells in 37°C for 2 hours with 0.125 mM palmitate (mixed with 0.8 Ci [n9,10-
3
H]palmitate) in the presence of 1 mM carnitine, and measuring the oxidation product 
([
3
H]HO) in media. (B) The same hepatocytes were subjected to extracellular flux 
analysis to measure oxygen consumption rate (OCR) before (baseline) and after the 
addition of 0.125 mM C16:0 or C18:1 in the presence of 1 mM carnitine.  These values 
were used to calculate the increase in OCR (OCR), shown in (C). All results were 
obtained from 4 animal-pairs (n=4), standardized against total proteins of hepatocytes and 
expressed as mean ± S.E. The flux analyses were performed in collaboration with Dr. 
Russell Swerdlow’s laboratory.*, p<0.05. White-bar: WT; Black-bar: Ncb5or
-/-
.    
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Figure 3.11 Changes in oxygen consumption rate (%OCR) in Ncb5or
-/-
 and WT 
hepatocytes in response to ETC related compounds. Hepatocytes were isolated and 
OCR were measured after sequential additions of (A) buffer, (B) oligomycin (inhibitor of 
mitochondrial ATP synthesis, 10 µM), (C) FCCP (carbonyl cyanide-p-trifluoromethoxy 
phenylhydrazone, mitochondrial uncoupler, 6 µM), and (D) rotenone/antimycin (complex 
I/III inhibitor, 4/8 µM, respectively).   Three sets of WT and Ncb5or
-/-
 hepatocytes (n=3) 
were tested and resulted in the same finding.  One representative pair is shown here with 
each data point measured in triplicates. Percentage change in OCR was calculated from 
comparison to the baseline OCR (prior to treatment).  Blue-bar: WT; Red-bar: Ncb5or
-/-
.  
This experiment was performed in collaboration with Dr. Russell Swerdlow’s laboratory. 
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3.4.4 Increased oxygen consumption and mitochondrial density in prediabetic Ncb5or
-/-
 
mice 
 We measured the whole body oxygen consumption of 5-week-old WT and 
Ncb5or
-/- 
mice using indirect calorimetry. We found Ncb5or
-/-
 mice consumed 
significantly more O2 than WT mice during fasting and fed periods (Figure 3.12 A). 
However, we did not observe any difference in respiration exchange ratios between WT 
and Ncb5or
-/-
 mice (Figure 3.12 B), suggesting no difference between the two genotypes 
in fuel substrates.   
 We previously observed increased mitochondrial biogenesis and oxidative 
metabolism in the hepatocytes of prediabetic Ncb5or
-/-
mice. To determine whether these 
cells have increased mitochondrial density, we used transmission electron microscopy to 
compare the ultrastructure of hepatocytes of Ncb5or
-/-
 and WT mice. We found that 
Ncb5or
-/- 
hepatocytes had higher mitochondrial numbers (Figure 3.13 A) and areas 
(Figure 3.13 B) than WT.  
To further confirm this finding, we used a different method to determine the ratio 
between mitochondrial and nuclear DNA, assuming that each mitochondrion contained 
the same copy number of DNA. , We observed higher mitochondrial : nuclear DNA 
ratios in Ncb5or
-/-
mice than WT (Figure 3.13 C).  
All these data suggest that Ncb5or
-/-
mice had increased mitochondrial density in 
the liver at age 5 weeks. Notably, we did not observe any difference in mitochondrial 
density between the two genotypes at age 2 weeks (Figure 3.14).  These results are 
consistent with PGC1α expression levels at these two ages (Table 2.1).  
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Figure 3.12 Whole body O2 consumption and respiration exchange ratio of chow-fed 
Ncb5or
-/-
 and WT mice. (A) O2 consumption of 5-week-old Ncb5or
-/-
 and WT mice was 
measured by indirect calorimetry and plotted as a function of time. Area-under-the-curve 
was calculated for each mouse during light (fasting) or dark (fed) cycle. (B) Respiration 
exchange ratio of CO2 production vs. O2 consumption (RER) of each mouse was 
calculated for each time point and averaged for the entire light (fasting) or dark (fed) 
cycle.  Results in (A) and (B) were obtained from 3 pairs (n=3) and plotted as mean ± S.E. 
Results are expressed as mean ± S.E.  *, p<0.05.  White-bar: WT; Black-bar: Ncb5or
-/-
.  
Dr. WenFang Wang fully contributed to this figure. 
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Figure 3.13 Hepatic mitochondrial content of chow-fed 5 week old Ncb5or
-/-
 and WT 
mice. (A) Representative TEM micrographs of Ncb5or
-/-
 and WT hepatocytes at five 
weeks of age  (B) Area of mitochondrial and cytosolic space was measured by the NIH 
ImageJ software and used to calculate the “mitochondria:cytoplasmic area”.  A total of 
three pairs (n=3, >10 cells per animal) were analyzed and results are expressed as mean ± 
S.E.  (C) Ratios of “mitochondria:nuclear DNA” (16s rRNA:hexokinase 2) were 
determined by qPCR.  A total of seven pairs (n=7) were analyzed and results are 
expressed as mean ± S.E.  *, p<0.05.  White-bar: WT; Black-bar: Ncb5or
-/-
.  
Dr. WenFang Wang performed OxyMax measurement and analyses, as well as most of 
TEM studies and image collection. 
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Figure 3.14 Hepatic mitochondrial content of chow-fed 2 week old Ncb5or
-/-
 and WT 
mice. (A) Representative TEM micrographs of WT and Ncb5or
-/-
 hepatocytes at age two 
weeks.  (B) Area of mitochondrial and cytosolic space was measured by the NIH ImageJ 
software and used to calculate the “mitochondria:cytoplasmic area”.  A total of three 
pairs (n=3, >10 cells per animal) were analyzed and results are expressed as mean ± S.E.  
All results are expressed as mean ± S.E.  *, p<0.05.   
White-bar: WT; Black-bar: Ncb5or
-/-
. Dr. WenFang Wang fully contributed to this figure. 
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3.4.5 Oxidative stress in liver of prediabetic Ncb5or
-/-
 mice 
 Ncb5or
-/-
 hepatocytes displayed higher rates of oxygen consumption, greater 
mitochondrial density, and higher levels of ROS and stress response than WT. Here we 
examined whether liver of Ncb5or
-/-
 mice had similar defects.  
We measured the transcript levels of oxidative stress response genes (MT1, MT2, 
HMOX1 and GSTT3) in the liver of newborn Ncb5or
-/-
 and WT mice and at age 2, 3, and 
5 weeks (Table 3.1). We found that all of the oxidative stress response genes were up-
regulated in liver of Ncb5or
-/-
 mice by 5 weeks but not earlier.  The timing of this 
response correlates to that of altered fatty acid metabolism in Ncb5or
-/-
 mice. 
Consistent with the above finding, a higher ratio of oxidized to reduced 
glutathione was observed in liver of Ncb5or
-/-
 mice than WT (Figure 3.15). There was no 
difference between the two genotypes, however, in the total glutathione level.  Higher 
transcript levels of oxidative stress response genes were also observed in liver of   
Ncb5or
-/-
 mice than WT after high-fat feeding (Table 3.2). Although HF diet restored 
hepatic TAG levels in Ncb5or
-/-
 mice, it did not attenuate the elevated levels of 
intracellular free fatty acid levels (Figure 2.7 A) and oxidative stress response in the 
livers. This result is different from that in hepatocytes.  Contributing factors to the 
difference between cell and animal models have been discussed previously (Section 
2.5.2).   
3.4.6  Lack of inflammation in liver of prediabetic Ncb5or
-/- 
mice 
 We next investigated whether increased oxidative stress could lead to 
pathophysiologic damage to liver of Ncb5or
-/-
 mice. Compared to WT, Ncb5or
-/-
 mice 
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displayed no elevation of hepatic marker enzymes in serum (data not shown), indicating 
no severe liver damage.  
We examined the following four markers of inflammation in the liver of these 
mice. Tumor necrosis factor-alpha (TNFα) is a cytokine involved in systemic acute phase 
inflammation [146] and is found to be stimulated by SFA-induced hepatic cytotoxicity 
[147].  Serum amyloid A (SAA) is also secreted during the acute phase of inflammation. 
SAA1 and 2 are major isoforms in livers and are regulated by proinflammatory cytokines 
such as TNFα and can be induced up to 1000-fold in livers under acute inflammatory 
condition [148].  
 A significant but mild up-regulation of all these markers (7-fold for TNFα and 2-
fold for SAAs) was observed in Ncb5or
-/-
 livers relative to WT at age 5 weeks (Table 3.1) 
and after HF feeding (Table 3.2). This minor induction in the expression of markers, 
however, did not lead to inflammatory response.  We measured TNFα protein levels in 
sera of Ncb5or
-/-
 and WT mice at age 5 weeks but found no difference between the two 
genotypes (data not shown). In addition, histologic analyses revealed no sign of 
inflammation in the liver of Ncb5or
-/-
 mice (Figure 3.16).  These tissues displayed no 
apoptosis by TUNEL staining (data not shown). Therefore, we concluded that no 
inflammation in Ncb5or
-/-
 mice up to age 5 weeks.    
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Table 3.1  Transcript levels of genes involved in oxidative stress and inflammatory 
responses in newborn, 2-, 3-, 5-week-old Ncb5or
-/-
 and WT mouse livers.  All values 
are mean ± S.E. (n=6) and relative to 18S (×10
6
). 
a
p<0.05, 
b
p<0.01, 
c
p<0.005. The 
transcript levels in bold indicate the significant difference. N.D. : Not determined 
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Figure 3.15 Oxidative stress markers in chow-fed Ncb5or
-/-
 and WT mouse liver 
tissue. Intracellular GSSG and GSH levels of six pairs of liver samples were measured 
(n=6) and shown as GSSG/GSH ratio in (A) and GSH+GSSG (total glutathione content) 
in (B).  All results were obtained from 5-week-old mice and expressed as mean ± S.E.  
*, p<0.05 White-bar: WT; Black-bar: Ncb5or
-/-
. 
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Table 3.2 Transcript levels of genes involved in oxidative stress and inflammatory 
responses in high-fat diet treated 5-week-old Ncb5or
-/-
 and WT mouse livers.  All 
values are mean ± S.E. (n=6) and relative to 18S (×10
6
). 
a
p<0.05, 
b
p<0.01, 
c
p<0.005.  
 
  WT Ncb5or
-/-
 
Fold ↑ in 
Ncb5or
-/-
 
MT1 37.8±9.1 354±70
c
 9.4 
MT2 7.40±2.04 89.1±14.7
c
 12 
HMOX1 3.12±0.39 10.6±1.4
c
 3.4 
GSTT3 1.96±0.38 9.50±2.23
c
 4.9 
TNF-α 0.40±0.05 0.61±0.11 1.5 
Saa1 3.63±0.72 8.40±2.67 2.3 
Saa2 0.77±0.12 2.82±1.13
a
 3.7 
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Figure 3.16 Hematoxylin and eosin (H & E) staining of representative liver sections 
of Ncb5or
-/-
 and WT mice under rodent chow. No macrophage or neutrophil 
infiltration was observed. Dr. WenFang Wang fully contributed to this figure. 
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3.5 Discussion 
3.5.1 Altered fatty acid metabolism in Ncb5or
-/-
 hepatocytes 
Our previous findings suggest that Ncb5or is an important enzyme involved in 
cellular metabolism of exogenous saturated fatty acid s. This pathway protects cells from 
SFA-induced cytotoxicity through converting SFA into MUFA and channeling MUFA 
and SFA into TAG pool. Our goal in the current study is to better understand how 
Ncb5or deficiency alters metabolism of SFAs and physiology of hepatocytes.  
Exogenous SFA have three metabolic fates after entering cells: 1) They stay 
inside the cell as intracellular nonesterified (free) fatty acids; 2) They are activated to 
their CoA esters for oxidation to provide energy; or 3) They are activated for 
phospholipids and TAG synthesis. Ncb5or
-/-
 hepatocytes accumulate more intracellular 
FFA in parallel to a more active catabolism under basal conditions.  
3.5.2 ER stress and oxidative stress 
 Ncb5or deficiency results in over-accumulation of intracellular free SFA, which 
has been shown to induce ER stress in many other studies [35; 86; 87]. Our data has 
shown that, when cells are pre-incubated in a nutrient rich medium, Ncb5or
-/-
 hepatocytes 
display less severe SFA-induced ER stress than that previously reported. However, our 
study reveals that Ncb5or deficiency predominantly results in increased fatty acid 
catabolism and a more active flux in mitochondrial ETC, which correlates to increased 
ROS production.    
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It is worth noting that ER stress plays an equally important, if not a more 
prominent, role in β-cell dysfunction and loss in Ncb5or
-/- 
mice. In our most recent study, 
we observed severe ER distension and significantly higher expression levels of ER stress 
response genes in Ncb5or
-/- 
β-cells than WT [34]. A better penetrance of ER stress in β-
cells may be due to a lower tolerance to ER stress imposed by their higher load for 
insulin synthesis and processing in β-cells compared to hepatocytes. Over-accumulation 
of intracellular free fatty acids and increased ROS production are observed in β-cells and 
hepatocytes of prediabetic Ncb5or
-/- 
mice, suggesting that altered fatty acid metabolism 
and increased ROS production are common cellular defects as a result of Ncb5or 
deficiency. 
3.5.3 Mechanism of cell death  
Ncb5or
-/-
 hepatocytes are more susceptible to SFA-induced cytotoxicity. Our 
current study has ruled out ceramide, phospholipid remodeling, and ER stress as the 
primary cause of cell death in Ncb5or
-/-
 hepatocytes.  However, it is still unclear how 
increased oxidative stress causes cell death. More experiments, such as treating Ncb5or
-/-
 
hepatocytes with antioxidant reagents with SFA, may help to address this point.  
Ncb5or
-/-
 hepatocytes have been previously shown to have increased TUNEL 
staining and Annexin V binding signals under SFA treatment [35; 36] .  We also detected 
higher caspase 3/7 activity in these cells than WT (data not shown).  These findings 
suggest that apoptosis is at least partially responsible for cell death in Ncb5or
-/-
 
hepatocytes. Measurement of lactate dehydrogenase in culture medium will be helpful to 
determine whether necrosis is also involved in Ncb5or
-/-
 hepatocytes.  
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In our current study, we were able to rescue SFA-induced cytotoxicity in Ncb5or
-
/-
 hepatocytes by co-incubation with MUFA, which channels free SFA into TAG pool. A 
similar regiment with a high-fat diet rich in both SFA and MUFA, however, still causes 
SFA-accumulation and oxidative stress in Ncb5or
-/-
 mice. It is worthwhile to use a 
MUFA-rich diet for similar rescue experiments. 
3.5.4 Conclusion 
In this chapter, we have characterized abnormal fatty acid metabolism, especially 
fatty acid catabolism and mitochondrial hyperactivity in Ncb5or
-/-
 hepatocytes and 
investigated the mechanism of SFA-induced cytotoxicity. We have also confirmed that 
Ncb5or
-/-
 mice have increased catabolism. We concluded that altered fatty acid 
metabolism in Ncb5or
-/-
 hepatocytes includes free SFA accumulation, enhanced fatty acid 
oxidation, compromised phospholipid synthesis and increased sensitivity to MUFA 
channeling. The aberration results in oxidative stress and eventually caused cell death, 
possibly by apoptosis. MUFAs rescue cell death and oxidative stress, apparently by 
decreasing the level of intracellular free SFA. Our study reveals an important role of 
Ncb5or in preventing oxidative stress and SFA cytotoxicity.  It has also expanded our 
knowledge of lipotoxicity. 
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Chapter 4 
 
 
 
 
Discussions and conclusions 
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4.1 Summary of current findings 
 Obesity and metabolic syndrome affect more than 20% of the population in the 
Unites States [47] and have become a major health issue in the past 20 years. Obesity 
increases the risk of coronary heart disease, type 2 diabetes, cancers, hypertension, stroke 
and fatty liver [149].  A better understanding of cellular fatty acid metabolism is critically 
important to our combat against this global health issue.  
We have shown that Ncb5or plays an important role in cellular fatty acid 
metabolism [36]. Ncb5or deficiency results in overt diabetes around 7 weeks of age.  Our 
studies in Chapter 2 examine the role of Ncb5or in fatty acid metabolism by employing 
hepatocytes and liver of pre-diabetic mice to avoid complications from diabetes. Our data 
suggest that Ncb5or facilitates SCD to convert SFA to MUFA, which is an essential part 
of TAG synthesis. We reveal a significant role of Ncb5or, in addition to Cyb5A, in fatty 
acid desaturation. Together, these findings establish the role of Ncb5or in fatty acid 
metabolism. 
 In Chapter 3, we explore the role of Ncb5or in protecting cells from oxidative 
stress. Oxidative stress has been implicated as a cause in a variety of diseases including 
atherosclerosis, Parkinson's disease, heart failure, myocardial infarction, Alzheimer's 
disease, cancer, fatty liver and diabetes. Our data suggest that Ncb5or exerts its effect by 
converting SFA to MUFA, which favors TAG synthesis and decreases levels of 
intracellular FFA and oxidative stress. Notably, Ncb5or deficiency does not impair 
cellular antioxidant system or MUFA’s ability of channeling SFA to intracellular TAG 
pool, because MUFA can alleviate SFA-induced cytotoxicity in Ncb5or-nul cells. 
111 
 
4.2 Future directions 
 Future studies are needed to answer some remaining questions and to test 
hypotheses as follows. 
 In Chapter 2, we showed that Ncb5or facilitates the function of SCD. However, it 
still remains unclear how Ncb5or fulfills this role. One hypothesis is that Ncb5or directly 
donates electrons to SCD. Further enzymatic activity assays using purified SCD protein 
will provide further evidence.  
Also in Chapter 2, we provided preliminary data on the functional relationship 
between Ncb5or and Cyb5A in ∆
9
 fatty acid desaturation. We will further dissect these 
pathways by applying isotope (
13
C) labeled exogenous SFA and acetate, which is the 
substrate of de no synthesis for SFA, to primary hepatocytes lacking either or both genes 
and tracing the metabolic fates of these isotope-labeled substrates, as previously 
described in studies using hepatoma cell lines [150]. 
Our recent preliminary data suggest that Ncb5or may be involved in cellular iron 
metabolism, potentially as a ferric reductase or its redox partner in cellular iron 
absorption. Iron deficiency and altered iron metabolism was observed in liver and 
duodenum of prediabetic Ncb5or null mice.  This defect may indirectly affect the activity 
of SCD, which requires iron for its catalytic activity. We present background information 
and preliminary data in the next section. 
 In Chapter 3, we showed that Ncb5or
-/-
 hepatocytes displayed higher levels of 
intracellular ROS and more cell death under SFA challenge, which is related to higher 
levels of intracellular free SFA in these cells than WT. Whether and how oxidative stress 
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causes cell death in Ncb5or
-/-
 hepatocytes is yet to be determined.  Treatment of these 
cells with antioxidants, such as N-Acetyl Cysteine (NAC), may help to answer this 
question. Further efforts to detect apoptosis and necrosis of Ncb5or
-/-
 hepatocytes will be 
helpful to determine cell death pathway for these cells. 
To better understand the physiological function of Ncb5or, it is important to 
identify the redox or physical partner of Ncb5or. Structural characterization of Ncb5or is 
desirable to further unravel the biochemical properties of Ncb5or.    
 
4.3 Potential role of Ncb5or in iron metabolism 
4.3.1 Iron metabolism 
Iron plays an essential role in a wide spectrum of redox reactions of metabolic 
pathways in all living organisms.  This function is due to iron’s readiness to accept and 
donate electrons by changing between ferric (Fe
3+
) and ferrous (Fe
2+
) redox states.  
Heme and iron-sulfur (FeS) clusters are two major forms of iron in proteins. Iron-
containing proteins are involved in essential biological processes, including oxygen 
binding, heme synthesis, energy generation, detoxification, nuclei acids metabolism, cell 
growth, and cell defending [151-153]. Iron homeostasis is critical for cellular physiology, 
because iron deficiency can impair cellular function, retard cell growth, and induce cell 
death [154; 155], whereas iron overload can induce oxidative stress and toxicity [156].  
Dietary non-heme iron uptake occurs in duodenal enterocytes (Figure 4.1). Ferric 
iron (Fe
3+
)
 
is reduced to the ferrous form (Fe
2+
), presumably by duodenal cytochrome b 
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(DcytB, or Cybrd1), before being transported into cytoplasm via divalent metal 
transporter (DMT1) [157]. Cybrd1 null mice display mild abnormality in iron metabolism, 
suggesting the existence of other ferric reductases [158]. These irons are then released 
from enterocytes into plasma through ferroportin (FPN), the basolateral iron exporter 
[159; 160].  Prior to binding to transferrin (TF) for circulation, Fe
2+
 needs to be oxidized 
to Fe
3+
 by hephaestin, because TF has higher affinity for Fe
3+
 than for Fe
2+ 
[161].  
Macrophages are the major places for iron recycle (Figure 4.1). The heme in aged 
and damaged erythrocytes are first exported from phagocytic vesicles by natural 
resistance-associated macrophages protein 1 (NRAMP1), a homologous to DMT1 [162], 
and iron is released by heme oxygenase (HMOX1) in cytosol, which are then exported 
into circulation similarly as in duodenum.  For most tissues, TF-bound iron is the major 
source of iron, and transferrin receptor (TFR1) plays a key role in cellular iron uptake. 
Following endocytosis of TF-iron molecules, Fe
3+ 
is released from TF and reduced to 
Fe
2+
 by STEAP (Six-transmembrane epithelial antigen of prostate) family for transport 
into cytosol via DMT1 [157; 163]. Meanwhile, apo-TF and TFR1 are recycled to cell 
surface for later use. Moreover, cells can also uptake iron via a TFR-independent 
pathway, in which ZRT/IRT-like protein 14 (ZIP14) and DMT1 are thought to play an 
important role [164].    
Iron homeostasis is maintained at both systemic and cellular levels in animals. At 
the systemic level, hepcidin (a peptide produced in liver) plays a key role in regulating 
the balance between iron demands (majorly from erythrocytes) and iron storage (mainly 
in hepatocytes, enterocytes and macrophages) by binding to FPN to trigger its 
internalization, ubiquitination, and degradation [165; 166].  This inhibits the release of 
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iron from cells and decreases levels of iron in circulation. Hepcidin expression is 
regulated by signals of iron abundance [167], bone morphogenesis, such as BMP6 [168; 
169], inflammation [170; 171], ER stress [172; 173], erythropoiesis [174], and hypoxia 
[175].  
At the cellular level, iron homeostasis is maintained by coordination of iron 
uptake, export, storage and utilization. Iron regulatory proteins 1 and 2 (IRP1 and IRP2) 
are two key regulators that bind to iron response elements (IREs) in target transcripts to 
either degrade or stabilize them [153]. Under iron deficient conditions, cellular iron 
uptake (TFR1 and DMT1) is induced, whereas iron storage (ferritin), export (FPN1) and 
utilization (heme synthesis) is repressed. The opposite processes take place when cells 
are overloaded with iron [153]. 
115 
 
 
Figure 4.1 Schematic diagram of iron metabolism.  For uptake and absorption, dietary 
Fe
3+ 
is first reduced to Fe
2+ 
on the apical membrane of duodenal enterocytes, potentially 
by Cybrd1. Iron is then transported into the cytoplasm via DMT1. Dietary heme is 
absorbed by an unknown mechanism, and iron is released from heme mainly by HMOX1. 
The major site for iron recycle is macrophages. The heme in aged and damaged red blood 
cells (RBC) is first exported from phagocytic vesicles by NRAMP1 and iron is released 
by HMOX1 in cytosol. Cytosolic Fe
2+
 is exported to circulation via ferroportin, oxidized 
to Fe
3+
 by hephaestin (enterocytes) or ceruloplasmin (macrophage), and then bound by 
transferrin for transportation to other tissues.   
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4.3.2 Iron deficiency in prediabetic Ncb5or
-/- 
mice 
To understand the biological function of Ncb5or, we performed microarray 
analyses of livers from Ncb5or
-/-
 and wild-type (WT) mice at age 5 weeks. We found 
significantly higher level of TFR1, HMOX1, MT1 and MT2 and > 20−fold lower level of 
hepcidin in Ncb5or
-/- 
livers compared to WT (data not shown). Altered expression of 
these genes has been observed in iron deficient rats [176].  Therefore, Ncb5or may play a 
role in iron metabolism, potentially reducing ferric irons in vivo, similar to its reductase 
property in vitro [6].  As shown below, Ncb5or deficiency leads to iron deficiency in 
liver, which could indirectly decrease the specific activity of stearoyl-CoA desaturase 
(Chapter 2), an iron-binding redox enzyme.   
We performed a survey of non-heme iron content among tissues of prediabetic 
Ncb5or
-/-
 mice at age 5 weeks.  By following a bathophenanthroline-based spectrophoto-
metric protocol [177], we observed lower iron content in liver, spleen, and duodenum in 
Ncb5or
-/-
 mice compared to WT, but similar iron content in brain, kidney, testis, ileum, 
and the whole pancreas between the two genotypes, under both fed and fasting states 
(Figure 4.2).  For unknown reasons, the iron content in heart is significantly lower in 
Ncb5or
-/-
 than WT only in mice fasted overnight.  Liver and spleen are two key organs 
for iron storage and recycle, respectively. Iron deficiency in these tissues progresses as 
Ncb5or
-/-
 mice age (data not shown).  Iron content in isolated islets will be measured 
through atomic absorption, which has a higher sensitivity (as low as 5 ppm) than the 
above method.  Results of our pilot runs indicate a general trend of lower iron content in 
islets of prediabetic Ncb5or
-/-
 mice than WT (data not shown).  
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Figure 4.2 Non-heme iron contents in tissues of prediabetic Ncb5or
-/-
 and WT mice 
under non-fasting and fasting states. Non-heme iron contents were measured in 
different tissues collected from 5-week-old Ncb5or
-/-
 and WT mice (C57BL/6 strain) at 
non-fasting state (A) or after fasted overnight (B). All values are expressed as mean ± S.E. 
(n>7) 
*, p<0.05 Blue-bar: WT; Red-bar: Ncb5or
-/-
.  
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Ncb5or
-/-
 mice at age 5 weeks display lower iron saturation of TF in circulation 
than WT and mild anemia (data not shown), suggesting a general iron deficiency.  To 
better understand Ncb5or’s potential role in iron absorption (duodenum) and storage 
(liver), as well as in diabetes that may be related to iron deficiency (islets), we performed 
qRT-PCR to analyze expression of key genes involved in iron metabolism.   
As shown in Table 4.1, Ncb5or
-/-
 duodenum displayed elevated levels of 
transcripts of TFR1 and DMT1 for iron uptake than WT under the fasting state, in which 
duodenums acquire iron mainly from circulation (TF-bound iron).  Increased iron uptake 
in Ncb5or
-/-
 mice was likely to compensate for their lower serum iron content (data not 
shown). This is supported by the lack of induction of TFR1 and DMT1 expression under 
non-fasting state, in which dietary iron is the main source for iron uptake in duodenum. 
No difference between the two genotypes was observed for HMOX1 and hephaestin 
transcript levels, indicating intact heme uptake and iron oxidation in Ncb5or
-/-
 duodenum.  
Notably, a 4 fold higher level of Cybrd1transcript was observed in Ncb5or
-/-
 
duodenum under non-fasting state. Cybrd1 has been proposed to play an important role in 
reducing dietary Fe
3+
 to Fe
2+
 prior to iron uptake via DMT1. The fact that Ncb5or 
deficiency induced Cybrd1 leads us to hypothesize that Ncb5or might played a similar 
role as Cybrd1 in vivo and that the induction of Cybrd1 compensates Ncb5or deficiency.  
This hypothesis will be further tested by: 1) Performing confocal immunofluorescence 
microscopy to determine whether Ncb5or may be associated with apical membranes of 
enterocytes, the same as Cybrd1; 2) Comparing iron deficiency in Ncb5or
-/-
 mice with 
Cybrd1 null and Ncb5or/Cybrd1 double null mice; 3) Measuring ferric reductase activity 
and iron absorption in duodenum of Ncb5or-null mice.  
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Table 4.1 Levels of transcripts of genes involved in duodenal iron metabolism in 
prediabetic Ncb5or
-/-
 and WT mice under both non-fasting and fasting states.  
Duodenum were collected from 5-week-old Ncb5or
-/-
 and WT mice (C57BL/6 strain) 
under non-fasting or fasting state. All values are mean ± S.E. (n=6) and relative to 18S 
(×10
6
). The transcript levels in bold indicate the significant difference. 
Duodenum 
 
Non-fasting   fold Fasting   fold 
  Wild-type Ncb5or
-/-
  
p-
value KO/WT Wild-type Ncb5or
-/-
  
p-
value KO/WT 
TFR1 31.6±5.6 33.3±3.2 N.S. 1.06 20.0±2.3 34.4±5.4 0.0239 1.72 
DMT1 13.6±4.8 18.9±6.4 N.S. 1.38 4.3±0.6 15.7±8.1 0.0367 3.65 
FPN1 61.6±22.0 112±30 N.S. 1.82 36.9±25.5 49.5±29.1 0.4873 1.34 
HMOX1 6.0±0.4 5.0±0.5 N.S. 0.82 3.8±0.3 7.8±2.6 0.2673 2.01 
Cybrd1 11.7±4.0 45.8±15.7 0.0235 3.91 2.2±0.7 2.3±0.6 N.S. 1.05 
Steap1 6.5±2.4 5.5±2.3 N.S. 0.84 1.4±0.2 1.5±0.2 N.S. 1.09 
Steap2 23.8±4.5 23.3±4.3 N.S. 0.98 11.8±0.9 12.3±0.5 N.S. 1.04 
Steap4 4.9±1.4 4.1±1.5 N.S. 0.84 1.8±0.2 2.2±0.3 N.S. 1.21 
ZIP14 16.9±3.0 13.3±1.6 N.S. 0.79 23.0±2.9 27.5±3.8 N.S. 1.20 
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To better understand iron mechanism in liver of Ncb5or
-/- 
mice, we measured 
levels of transcripts of iron metabolism genes at different ages (Table 4.2). Compared to 
WT, Ncb5or
-/- 
livers had similar gene expression pattern after birth, except slightly higher 
expression of IRP1, ferritin light chain (FTL), and Steap4. After these mice reached age 2 
weeks, they started to show more significant alteration of iron metabolism in liver. Most 
(or all) of STEAP isoforms and DMT1 were up-regulated in Ncb5or
-/- 
livers at age 2 and 
5 weeks. The levels of TFR1 and ZIP14 transcripts were also higher in these livers at age 
5 weeks than WT. TF bound irons are the main iron source in hepatocytes. After TF 
binds TFR, Fe
3+
 is released and reduced to Fe
2+
 by STEAPs and transported into cytosol 
by DMT. Up-regulation of genes in this pathway in Ncb5or
-/- 
livers indicates a potential 
compensation for impaired iron uptake in these cells.  
Ncb5or might play a role in reducing ferric iron by itself or together with STEAPs. 
Unlike other STEAPs, STEAP1 has no flavin-binding reductase domain [178], therefore 
can function only in the presence of a reductase such as Ncb5or. The strong induction 
(more than 15 fold) of STEAP1 at age of 5 weeks, compared to moderate induction (less 
than 2 fold) of other STEAPs, appears to suggest that Ncb5or may be a potential working 
partner with STEAP1. Interestingly, STEAP1 was down-regulated at age 2 weeks while 
other STEAP isoforms were up-regulated. This could be a transient stage for the 
regulation of STEAP1, and may suggest that STEAP1 works differently than other 
STEAPs. ZIP14 played roles in both TFR dependent and independent pathways for iron 
uptake. Induction of this gene was consistent with a compensation mechanism of iron 
deficiency in Ncb5or
-/- 
livers.  
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Transcript levels of mitofn (mitoferrin)1 and 2 were similar between the two 
genotypes, indicating that Ncb5or
-/- 
hepatocytes have intact mitochondrial iron transport.   
Hepcidin is the major regulator for systematic iron homeostasis. We observed a 
noticeable age-dependent regulation of hepcidin in Ncb5or
-/-
 mouse model. Hepcidin was 
expressed at a level that was > 9-fold higher in Ncb5or
-/-
 livers than WT at age 2 weeks 
(Table 4.2) and 3 weeks (data not shown). Elevated hepcidin expression increased the 
degradation of FPN and resulted in decreased iron export. This could explain why 3-
week-old Ncb5or
-/-
 mice had similar hepatic iron content (data not shown) despite 
impaired iron uptake. However, at age 5 weeks, Ncb5or
-/-
 livers had 10-fold lower 
hepcidin level compared to WT. Although this difference was not significant due to 
individual variance, the opposite trend between this and earlier age (2 and 3 weeks) is 
intriguing and deserves more investigation.  
Since hepatocytes served as major iron storage sites, their major role under fasting 
state was to export iron to other tissues. The two genotypes displayed similar expression 
pattern (data not shown) under this state, indicating no major defect of iron export in 
Ncb5or
-/-
 livers. Less than 2 fold induction of ZIP14 was the only exception. The role of 
ZIP14 requires more investigation due to its inconsistent regulation in Ncb5or
-/-
 mouse 
livers.  
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Table 4.2 Levels of transcripts of genes involved in hepatic iron metabolism in 
newborn, 2 and 5-week-old Ncb5or
-/-
 and WT mice under non-fasting state. Livers 
were collected from newborn, two and five weeks old Ncb5or
-/-
 and WT mice (C57BL/6 
strain). All values are mean ± S.E. (n=6) and relative to 18S (×10
6
). The transcript levels 
in bold indicate the significant difference. 
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           Iron has been found to play an important role in diabetes. Iron overload is strongly 
associated with type 2 diabetes [179]. Excessive tissue iron could lead to oxidative stress 
through Fenton reaction and induce insulin resistance [180]. Iron overload could decrease 
glucose utilization and increase glucose production [181]. What is more, iron deficiency 
could protect high-fat induced muscle insulin resistance [182]. These studies provide 
valuable knowledge about the relationship between iron metabolism and diabetes. Our 
model is unique, however, because diabetes in Ncb5or
-/-
 mice is associated with iron 
deficiency instead of iron overload.  
We also determined levels of transcripts of genes involved in islet iron 
metabolism by qRT-PCR.  We observed altered iron metabolism in Ncb5or
-/-
 islets at age 
5 weeks at the transcript level (Table 4.3). It is foreseeable that iron deficiency in Ncb5or
-
/-
 islets causes improper function of key enzymes, and resulted in altered fatty acid 
metabolism and -cell death. The exact mechanism and relationship between iron 
deficiency and diabetes, however, is far from clear and requires more in-depth studies. 
Based on the above preliminary data, we hypothesize that Ncb5or is important for 
dietary iron absorption in duodenum and for cellular iron uptake in hepatocytes.  Ncb5or 
functions either as a ferric reductase or an electron donor of ferric reductase, such as 
Cybrd1, to facilitate iron update. Our future study will test this hypothesis and explore the 
mechanism of iron deficiency in Ncb5or-null cells, especially its functional relationship 
to altered fatty acid metabolism. If our hypothesis is proven to be correct, the new 
knowledge will help us to understand how iron homeostasis contributes to cellular fatty 
acid metabolism.
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Table 4.3 Levels of transcripts of genes involved in islet iron metabolism Ncb5or
-/-
 
and WT mice at age 3 and 5 weeks. Islets were collected Ncb5or
-/-
 and WT mice 
(C57BL/6 strain). All values are mean ± S.E. (n=6) and relative to 18S (×10
6
). The 
transcript levels in bold indicate the significant difference.                   
Dr. Wenfang Wang contributed to this table. 
  3-week   fold 5-week   fold 
  
Wild-
type Ncb5or
-/-
  p-value KO/WT Wild-type Ncb5or
-/-
  p-value KO/WT 
TFR1 16.1±3.7 16.9±3.7 0.8985 1.05 1.7±0.3 7.0±1.5 0.0010 4.15 
IRP1 8.4±2.2 6.7±0.7 0.4949 0.79 1.1±0.2 4.4±0.4 0.0003 4.11 
IRP2 16.0±4.4 11.8±3.4 0.5429 0.74 2.4±0.6 9.9±2.0 0.0034 4.13 
DMT1 5.2±1.1 4.2±0.1 0.3609 0.80 0.37±0.07 1.4±0.5 0.0141 3.83 
FPN1 11.8±0.9 8.8±2.2 0.3645 0.74 1.0±0.23 4.2±1.0 0.0056 4.11 
Cybrd1 1.0±0.2 6.8±2.4 0.0109 6.67 0.21±0.09 0.60±0.30 0.2684 2.84 
FTH 357±59 498±49 0.1657 1.39 43.9±10.4 64.6±18.8 0.3982 1.47 
FTL 3499±753 4696±742 0.3609 1.34 311±59 378±92 0.5879 1.22 
ZIP14 6.7±0.6 3.8±0.4 0.0162 0.56 0.98±0.06 2.3±0.5 0.0126 2.32 
Steap1 464±66 806±2 0.1133 1.74 55.1±10.5 54.9±0.5 0.9066 1.00 
Steap2 274±56 473±51 0.0380 1.73 28.1±6.9 40.9±5.4 0.1221 1.46 
Steap3 3.8±1.0 1.7±0.3 0.0792 0.44 0.46±0.21 1.9±0.7 0.0157 4.05 
Steap4 313±51 386±29 0.2199 1.23 32.7±7.0 38.5±10.9 0.7732 1.18 
Mitofn1 3.5±0.7 4.1±0.16 0.3055 1.19 0.62±0.2 1.8±0.5 0.0234 2.94 
Mitofn2 8.3±1.8 7.0±1.7 0.6147 0.84 1.2±0.3 6.6±1.1 0.0003 5.41 
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